Next Article in Journal / Special Issue
Testing the Efficacy of the Synthesis of Iron Antimony Sulfide Powders from Single Source Precursors
Previous Article in Journal
Synthesis and Antiparasitic Activity of New Conjugates—Organic Drugs Tethered to Trithiolato-Bridged Dinuclear Ruthenium(II)–Arene Complexes
Previous Article in Special Issue
Insights into the Antimicrobial Potential of Dithiocarbamate Anions and Metal-Based Species
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Inorganics
Volume 9
Issue 8
10.3390/inorganics9080060
inorganics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Dithiocarbamate Complexes of Platinum Group Metals: Structural Aspects and Applications

by
Yee Seng Tan
1,*,
Chien Ing Yeo
1,
Edward R. T. Tiekink
1 and
Peter J. Heard
2,*
1
Research Centre for Crystalline Materials, School of Medical and Life Sciences, Sunway University, Bandar Sunway 47500, Selangor Darul Ehsan, Malaysia
2
Chancellery Office, Sunway University, Bandar Sunway 47500, Selangor Darul Ehsan, Malaysia
*
Authors to whom correspondence should be addressed.
Inorganics 2021, 9(8), 60; https://0-doi-org.brum.beds.ac.uk/10.3390/inorganics9080060
Submission received: 29 June 2021 / Revised: 15 July 2021 / Accepted: 19 July 2021 / Published: 22 July 2021
(This article belongs to the Special Issue Metal Dithiocarbamate Complexes: Versatile Ligands in Coordination Chemistry with Applications in Medicine, Materials Science, and Beyond)
Browse Figures
Versions Notes

Abstract

:
The incorporation of dithiocarbamate ligands in the preparation of metal complexes is largely prompted by the versatility of this molecule. Fascinating coordination chemistry can be obtained from the study of such metal complexes ranging from their preparation, the solid-state properties, solution behavior as well as their applications as bioactive materials and luminescent compounds, to name a few. In this overview, the dithiocarbamate complexes of platinum-group elements form the focus of the discussion. The structural aspects of these complexes will be discussed based upon the intriguing findings obtained from their solid- (crystallographic) and solution-state (NMR) studies. At the end of this review, the applications of platinum-group metal complexes will be discussed.

Graphical Abstract

1. Introduction

Dithiocarbamates (RR′NCS2−; Figure 1) are highly versatile ligands that have attracted the attention of coordination chemists for decades [1,2,3,4,5]. These, usually, mono-anionic species normally coordinate in an essentially symmetric fashion via the two sulfur atoms and are able to form stable complexes with a remarkable range of different metals in a variety of different oxidation states, including those that are higher than normal. This being stated, bridging modes of coordination are sometimes observed in the structural chemistry of the main group elements [6,7,8,9]. It is also noted that polyfunctional dithiocarbamate ligands, that is, bearing more than one CS2− residue, are known although comparatively rare [10] as are multifunctional ligands incorporating CS2− functionality as well as other coordinating sites, for example, pyridyl donors [11]. The latter two classes of ligand are invariably bridging and lead to various multi-metallic aggregates.
The versatility of dithiocarbamate ligands stems from the near equal contributions of the two resonance forms, I and III (2 × 30%) and II (40%) (Figure 1). This is also significant in terms of supramolecular chemistry as the resulting MS2C chelate ring has significant π-character, metallo-aromaticity [12], and can participate as an acceptor in C–H⋯π(chelate ring) interactions in the same way as C–H⋯π(arene) interactions [13,14] but impart greater energies of stabilization [15,16,17].
From a structural point of view, dithiocarbamate complexes are of interest precisely because of the range of different heavy element ions to which they can coordinate and the resulting structural motifs. In summary, recent work has uncovered an even more diverse molecular and supramolecular chemistry with a wide variety of structural arrangements.
However, dithiocarbamate complexes are not just of intrinsic interest. Dithiocarbamates themselves are biologically active and when coupled with different metals, transition metals and main group elements, which often show enhanced activity, this activity can be modified, fine-tuned, and amplified [18,19,20,21,22]. Dithiocarbamate complexes also show utility as single-source precursors to metal sulfide nanoparticles [23,24]. It is thus unsurprising there has been no let-up in recent years in the number of dithiocarbamate complexes reported in the literature. In this review, we explore recent advances in the molecular chemistry of platinum-group metal dithiocarbamate complexes, focusing on structural data acquired via X-ray crystallography and multi-NMR spectroscopy as well as an overview of potential applications. In many of these complexes, the dithiocarbamate ligands have been incorporated because of their ability to stabilize the metal moiety, allowing other, active functional groups to be present. In other cases, it is the dithiocarbamates themselves that are the primary focus of interest. In either case, without the presence of such a stable and tolerant ligand as dithiocarbamate, the potential utility of the resultant complexes is likely to be diminished.
Homoleptic dithiocarbamate complexes are typically prepared in a single-pot synthesis from the reaction of a secondary (or, less commonly, primary) amine with carbon disulfide under basic conditions and in the presence of the appropriate metal ion synthon (Equation (1)) [25]. Alternative routes, more applicable to heteroleptic complexes include the reaction of a suitable dithiocarbamate salt (typically the ammonium [26], Group 1 [27] salt) with a metal halide (Equation (2)), or insertion of CS2 into the metal-nitrogen bond of the corresponding amide complex (Equation (3)) [28].
nNHR 2 + nCS 2 + M n + → OH − S 2 CNR 2 n + H 2 O
nX S 2 CNR 2 + M n + Y n → M S 2 CNR 2 n + nXY
M NR 2 n L + nCS 2 → M S 2 CNR 2 n L
R = alkyl/aryl; M = metal; X = cation; Y = halides; L = ancillary ligand.

2. Methods

A systematic search of the Cambridge Structural Database (CSD, version 5.42) [29] employing ConQuest (version 2.0.4) [30] was performed for the present bibliographic review of the crystallographic literature where the search evaluated all platinum-group metals (Ru, Rh, Pd, Os, Ir, and Pt) structures bearing a NCS2 moiety. The search was restricted to structures deposited from 2004 onwards. No other restrictions were applied. All crystallographic diagrams were generated employing DIAMOND [31] using the Crystallographic Information Files deposited for each structure.

3. Results

The solid-state structures revealed by X-ray crystallographic methods will be discussed initially. This will be followed by an evaluation of solution-state structures/chemistry established by multi-NMR studies as well as an overview of complementary solid-state NMR studies. Lastly, comments will be made on the potential applications of the platinum group metal dithiocarbamate complexes.

3.1. Solid-State Structures

The discussion of the platinum group metal dithiocarbamate structures is made in the order following the Group of the Periodic Table, followed by the classification of the complexes such as binary, ternary, etc., and lastly, as organometallic species. A general overview of molecular structures will be provided and molecular packing only described for examples showing intriguing interactions. The dithiocarbamate ligands employed in this review are shown in Table 1 and Figure 2. The full chemical composition for the crystals discussed is included in the respective table under each subsection.

3.1.1. Ruthenium

The CSD search for ruthenium complexes bearing a dithiocarbamate ligand consistent with the search parameters described in Section 2 resulted in 72 different crystal structures: these are listed in Table 2. The most common oxidation states of ruthenium complexes are +II and +III with ruthenium(II) complexes being the most predominant. Generally, the ruthenium complexes adopt octahedral coordination geometries with the common feature of the dithiocarbamate acting as a κ2 ligand. Binary complexes 1–5 feature ruthenium(III) centers while ternary (6–17) and quaternary (21) complexes constitute a ruthenium(II) metal center whereas crystals of 18–20 have ruthenium(III) centers. The organization of the remaining structures, namely 22–72, is problematic. The common feature of 22–49 is the presence of at least one carbonyl ligand, 50–55, a cyclopentadienyl (Cp) ligand and 56–66, a pentamethylcyclopentadienyl (Cp*) ligand. It is acknowledged this categorization is arbitrary. For example, the complex in crystal 55 contains both CO and Cp while crystal 66 contains both CO and Cp*. The last set of organometallic complexes 67–72, containing neither CO, Cp nor Cp*, are discussed in more detail below.
Crystals 1–3 [25] feature binary tris dithiocarbamate complexes. The presence of three symmetrically chelating ligands defines an octahedral geometry and enables the formation of enantiomers, i.e., Δ and Λ. A representative example is shown in Figure 3a being the Δ-enantiomer of 1. The Ru-S bond lengths are equivalent and the main distortions from the ideal geometry arise as a consequence of the small bite angle of the chelating dithiocarbamate ligands. Two crystals have dinuclear [Ru2(L8)5]+ cations. Despite the common formulation, two distinct patterns of coordination are noted. In the crystal of 4 [32], Figure 3b, two dithiocarbamate ligands bridge the two ruthenium atoms, chelating one and simultaneously bridging the other via one sulfur atom only. The third ligand is also bridging but forms only one bond to each ruthenium atom; the remaining dithiocarbamate ligands are chelating. As shown in Figure 3c, in 5 [33], two dithiocarbamate ligands bridge the two ruthenium atoms by chelating one and simultaneously bridging the other via one sulfur atom only. The bridging dithiocarbamate ligands are connected to the same ruthenium atom. The S6-octahedral geometry for each metal center is completed by one and two chelating ligands, respectively. The presence of different counter ions and solvates in the crystal may be responsible for the observed behavior.
Attention now turns to ternary complexes. In common with 1–5, mononuclear complexes in 6 [32], Figure 3d, and 7 [32] feature octahedral geometries defined by S6 donor sets. In the latter, the S-bound DMSO molecules occupy cis-positions with the dithiocarbamate ligands chelating in a slightly asymmetric mode with the longer Ru-S(dithiocarbamate) bonds occupying positions trans to the DMSO-S atoms. In crystals, 8 [34], 9 [35], and 10 [34], Figure 3e, the DMSO molecules of 6 and 7 have been substituted by a chelating dppb ligand leading to cis-P2S4 donor sets. The number of dithiocarbamate ligands in the remaining structures, 11 to 21 is reduced to one. In the cationic salts 11 [36], Figure 3f, and 12 [37], the 2,2′-bipyridyl ligands are each chelating so the donor set is cis-N4S2. A similar geometry is found for the cation in 13 [38] where the four nitrogen atoms of the former examples are now replaced by the amine-nitrogen atoms of the cyclam ligand. The ruthenium center in the complexes of crystals 14 [39], 15 [40], 16 [41], and 17 [42] have the common feature of bearing two chelating dppm ligands and in a sense, the resulting cis-P4S2 coordination geometries are the inverse to those seen in the crystals of 8 to 10. The heterometallic dinuclear complex in 17, Figure 3g, is worthy of special mention in that the ruthenium and square planar palladium atoms are connected by a multifunctional dithiocarbamate dianion, L74. The neutral complexes in quaternary crystals of 18 [43], 19 [44], and 20 [44] have trans PPh3 ligands with the chloride atoms occupying positions trans to the sulfur atoms of the chelating dithiocarbamate ligands; a representative molecule, i.e., 18 is illustrated in Figure 3h. The final non-organometallic molecule to be described in this section is the cation in 21 [45]. Here, the nitrogen atoms of the tridentate tptz ligand occupy mer-positions in the octahedral geometry defined by the N3PS2 donor set, Figure 3i.
The common feature of organometallic species 22–49 is the presence of at least one carbonyl ligand: indeed, all but 48 (two) and 49 (three) have one terminally bound carbonyl group. In each of 22 [46] and 23 [47], there are two dithiocarbamate ligands while the remaining structures have one dithiocarbamate each. In 22, Figure 4a, the ruthenium(II) center is bis chelated by two dithiocarbamate ligands with the distorted octahedral geometry completed by the phosphane and carbonyl ligands. In 23, Figure 4b, one of the dithiocarbamate ligands of 22 now bridges an already coordinated germanium atom, forming one bond to each atom with the resultant octahedral coordination geometry based on a CGePS3 donor set. The common feature of 24–26 [48] is a CNPS2Si donor set as one of the chelating dithiocarbamate ligands of 22 is replaced by a Si∩N chelating ligand with the difference in structures related to the backbone of the Si∩N chelating ligand; the molecule in 24 is shown in Figure 4c. In 27 [49], the dithiocarbamate and phosphane ligands of 22 are replaced by a tridentate ligand where coordination occurs from the ring-boron atom and two pendant phosphane ligands, Figure 4d. Thus, this is the first example where ruthenium is coordinated by two phosphane ligands representing a key structural difference from 22–26. The common feature of the complexes in the crystals of 28–47 is that they conform to the general formula (PPh3)2Ru(Ln)(CO)Y. For 28 [50], 29 [48], Figure 4e, and 30 [51], Y is a hydride. In common with all structures up to an including 43, the phosphane ligands are mutually trans. Similar arrangements are found in 31 [48] and 32 [47] where the hydride has been substituted for Si(Cl)Ph2 and Ge(p-tolyl)3 groups, respectively.
The (PPh3)2Ru(Ln)(CO) framework figures prominently in the stabilization of a variety of ruthenium-bound alkenes and alkynes. Alkenes of the type C(H)=C(H)R feature in the structures of 33 [52], Figure 4f, 34 [39], 35 [40], 36 [53], and 37 [51], whereas those of the type C(C≡R′))=C(H)R are seen in 38 [51], Figure 4g, 39 [54], and salt 40 [55]. Alkynes are observed in 41 [52] and 42 [52]. In 43 [56], Figure 4h, there is a Ru–C(phenyl) bond. The introduction of chloride to replace the alkene, alkyne, and phenyl ligands of 33–43 results in a major readjustment of the coordination geometry in that the phosphane ligands are now cis. The crystals of 44–47 [52] contain the same complex species but differ in the nature of the crystalline solvent; the molecule of 44, being representative, is shown in Figure 4i. The complex molecule in 48 [47] is different from the previous carbonyl compounds in that there are two carbonyl groups, occupying positions trans to the dithiocarbamate-sulfur atoms; the phosphane and Ge(p-tolyl)3 ligands are trans within the octahedral geometry defined by a C2GePS2 donor set, Figure 4j. In 49 [57], a tri-carbonyl species lacking a phosphane ligand, the carbonyls occupy one octahedral face with the remaining sites defined by dithiocarbamate-sulfur and chloride atoms, Figure 4k.
The other common ligands featuring in the ruthenium dithiocarbamates are those based on cyclopentadienyl, namely the parent Cp and permethylated Cp* ligands. Molecules in the crystals 50–55 feature Cp and three district structural motifs are evident. The molecules in 50 [58], 51 [59], 52 [58], and 53 [60] conform to the same motif shown in Figure 5a for 50, notable for having a dissymmetric dithiocarbamate ligand. The ruthenium is coordinated by a chelating dithiocarbamate ligand, a phosphane and the three remaining positions in the octahedral geometry defined by the Cp ligand. A similar coordination geometry pertains in the dinuclear species 54 [61] where two ruthenium atoms are linked by a dppf molecule, Figure 5b. In 55 [62], a mixed carbonyl/cyclopentadienyl compound, the former effectively substitutes for a phosphane ligand leading to an octahedral geometry-based, formally, on a C4S2 donor set, Figure 5c.
Among the Cp* structures, a new motif is noted for 56 [63] and 57 [64], with that of cationic 57, with a dissymmetric dithiocarbamate ligand, illustrated in Figure 5d. Here, the ruthenium is chelated by two dithiocarbamates and is capped by a Cp* resulting in, formally, a seven coordinate geometry based on a piano stool. A similar geometry is formed in neutral 58 [65], Figure 5e, and 59 [64] where one dithiocarbamate ligand has been replaced by two chlorides. Similar neutral species are seen in 60 [64] and 61 [64], Figure 5f, where the one dithiocarbamate ligand of 56 has been substituted by dinegative dithiocarbonate. The geometries of the cations in 62 [64] and 63 [64], resembling that seen in Figure 5c for 55 whereby the carbonyl has been substituted for a chloride. A variation is observed in 64 [65] as dimerization has occurred leading to the dicationic species shown in Figure 5g and a coordination geometry based on a piano stool. A piano stool geometry is also noted for dicationic 65 [65]. The molecule in 66 [64] is the Cp* analogue of 55 shown in Figure 5c.
The remaining structures to be described may be considered miscellaneous organometallic species as they contain neither carbonyl nor cyclopentadienyl type ligands. For the cations in 67 [43], Figure 5h, and 68 [43], the ruthenium is chelated by a dithiocarbamate as well as C,N-chelated by the C(NMe2)XC(NMe2)=S, X = O (67), S (68), ligand with the octahedral geometry completed by two trans oriented phosphane ligands. Cationic structure 68 was derived from 18 whereby 18 was treated with one molar equivalent of [M(MeCN)4][ClO4] (M = Cu, Ag) which resulted in C-S bond cleavage of L8 and reassembly with another L8 anion to generate the C,S chelating ligand. Prolonged standing resulted in hydrolysis and the ligand shown in Figure 5h. The common feature of 69 [66], Figure 5i, 70 [66], and 71 [66] is the presence of the di-allyl type ligand, (η3, η3–2,7-dimethylocta-1,6-dien-3,8-diyl), which is assumed. Finally, the molecule in 72 [67], with a p-cymene ligand, assumes a coordination geometry resembling that of in 55 in Figure 5c.
As mentioned in the Introduction, crystals of metal dithiocarbamates are prone to display assemblies featuring C–H⋯π(metal-S2C) interactions [15,16,17]. While the focus of the present overview is upon molecular geometries, it is worth highlighting some examples drawn from the ruthenium dithiocarbamates 1–72 where C–H⋯π(RuS2C) interactions are evident in their crystals. In Figure 6a, a supramolecular dimer is formed in the crystal of 3 through intermolecular C–H⋯π(RuS2C) interactions occurring between centrosymmetrically related molecules. A similar aggregate is formed in the crystal of 8 despite the presence of bulky phosphane ligands. Supramolecular chains are also evident, for example in the crystal of 1 where a zigzag chain is evident with each independent molecule forming on average two C–H⋯π(RuS2C) interactions. In the crystal of 58, a helical chain features C–H⋯π(RuS2C) interactions.

3.1.2. Rhodium

As summarized in Table 3, there are five known rhodium dithiocarbamate structures reported in the timeframe of this review.
In keeping with the predominance of octahedral coordination geometries about the rhodium dithiocarbamate structures in 73–77, in 73 [68], one of the dithiocarbamate ligands adopts a relatively rare monodentate mode of coordination while the other retains its usual chelating mode. The three remaining positions in the octahedral geometry are occupied by the nitrogen atoms of the tripodal Tp* ligand, Figure 7a. Figure 7b gives a representation of the hydride in 74 [69]. Stabilization to the molecule is provided by the tripodal ligand which coordinates by the central silicon atom and the two phosphorus atoms leading to a HP2S2Si donor set as the dithiocarbamate ligand is coordinating in the anticipated chelating mode. The molecules in 75 [70], Figure 7c, and 76 [71], are closely related with the rhodium atom being coordinated by a chelating dithiocarbamate ligand and two C,N-chelating 2-(pyridin-2-yl)phenyl ligands with the nitrogen atoms being mutually trans. Finally, in 77 [72], Figure 7d, a C2P2S2 donor set is apparent owing to the presence of a chelating 1,2-bis(2-phenylethynylmethylene)cyclohexane ligand, the phosphorus atoms are mutually trans.

3.1.3. Palladium

A total of 79 distinct structures have been identified for palladium dithiocarbamates, Table 4. Despite the rather large number of structures, there is limited structural diversity among these so there are less than 10 distinct structural motifs in this category. The molecules contain palladium(II) centers and are generally considered four coordinate complexes within a square planar coordination geometry; in all cases the dithiocarbamate ligand functions as a κ2 ligand. This is exemplified for the binary complexes of the general formula Pd(Ln)2: 78 [73], 79 [74,75,76], 80 [77], 81 [78], 82 [79], 83 [80], 84 [81], 85 [82], 86 [83], 87 [84], 88 [79], 89 [78], 90 [79], 91 [85], 92 [86], 93 [87], 94 [79], 95 [88], 96 [89], 97 [90], and 98 [91]. A representative molecule for 78–98 is that of Pd(L13)2 (81) shown in Figure 8a. Here, the palladium atom is bis-chelated by two dithiocarbamate ligands resulting in a square planar geometry defined by a S4 donor set. The next three binary palladium dithiocarbamates are constructed with multifunctional dithiocarbamate ligands, that is, bearing two CS2− functionalities. Thus, in 99 [92], 100 [92], Figure 8b, and 101 [93] two palladium atoms are bridged by two such ligands giving rise to the anticipated S4 donor sets, the aggregates in 99 and 101 are disposed about a center of inversion. The final binary complex is exceptional in that the polyfunctional dithiocarbamate ligand bears two phosphane donors. As shown in Figure 8c for the dication in the crystal of 102 [94], each dithiocarbamate ligand chelates one palladium atom via the sulfur atoms and the second palladium atoms via the phosphane atoms giving rise to a centrosymmetric aggregate and P2S2 donor sets.
The ternary crystals 103 [95], 104 [95], 105 [96], 106 [97], and 107 [97], feature square planar N2S2 donor sets defined by chelating dithiocarbamate and N∩N ligands. An example is illustrated for (fcdpm)Pd(L43) (105) in Figure 8d which is notable for having both ligands bearing a ferrocenyl (Fc) group. The next series of square planar complexes have P2S2 donor sets with the phosphorus atoms derived from bidentate phosphane ligands in the mononuclear cations 108 [26], 109 [98], and 110 [99]. Bifunctional dithiocarbamates feature in complexes with monodentate phosphane ligands in dinuclear 111 [100], 112 [100], and 113 [100], and bidentate phosphanes in dinuclear 114 [101] and 115 [102]; a representative complex is shown for {[(PPh3)2Pd]2(L85)}2+ of 113 in Figure 8e. Quaternary molecules of the general formula (PR3)Pd(Ln)Cl are found in 116 [103], 117 [104], 118 [105], 119 [26], 120 [106], 121 [104], 122 [107], 123 [107,108], 124 [109], 125 [110], 126 [111], 127 [110], 128 [112], 129 [113], 130 [114], 131 [112], 132 [112], 133 [113], 134 [114], 135 [115], 136 [103], 137 [109], 138 [109], 139 [110], 140 [111], 141 [116], 142 [117], 143 [117], 144 [116], and 145 [115]. The square planar coordination geometries have ClPS2 donor sets; a representative molecule is shown in Figure 8f for (PPh3)Pd(L81)Cl in 122. In 146 [104], the chloride has been replaced by a thiocyanate ligand leading to a PS3 donor set. The remaining structures in this category are deserving of special mention and/or are organometallic in nature.
In the crystal of 147 [118], the neutral complex, Figure 9a, features a P2S2 square planar geometry defined by, formally phosphane, tBu(Ph)POH, and P-bound phosphinoyl, [tBu(Ph)PO]− ligands as well as a chelating dithiocarbamate. However, in the crystal, the hydrogen atom is equally shared by the oxygen atoms, a feature of the molecule reflected in the equivalence of the Pd-P bond lengths. In 148 [118], Figure 9b, a similar coordination geometry is found with the palladium atom bound by two phosphinoyl-P atoms. A central copper(II) atom is also in a square planar geometry but defined by, formally, four oxido-O atoms. The complexes in 149 [119], 150 [120], 151 [121], 152 [122], and 153 [123] feature C,N-chelating ligands and CNS2 donor sets. An impressive example is that of 152, Figure 9c, being notable for the tethering, via cyclometallation, of the palladium dithiocarbamate complex to a nickel(II) porphyrin. Whereas 149–153 featured chelating C,N ligands, in the phosphane complex 154 [124], Figure 9d, the CPS2 donor set comprises monodentate phosphane and pyrimidin-5-yl ligands as well as the chelating dithiocarbamate ligand. The final two examples, that is 155 [77], Figure 9e, and 156 [77], formally feature C2S2 donor sets with the two coordination sites in addition to those provided by the dithiocarbamate ligand occupied by carbon atoms derived from the η3–2-methylallyl ligand.

3.1.4. Osmium

Nearly 80% of the structures identified for organometallic osmium(II) dithiocarbamates, crystals 157–176, are mainly contributed by Wright et al. over four years i.e., 2004 to 2007 with the primary motivation being interest in their reactivity [125,126,127,128,129]. The majority of the osmium centers have a coordination number six and exhibit octahedral geometry. Of note, all structures but 176 feature L8; the exceptional structure, i.e., 176, has L24. A list osmium dithiocarbamate structures appears in Table 5.
Of the mononuclear molecules, 157 [130] is exceptional for two reasons: it is the only molecule with two dithiocarbamate ligands and does not feature a phosphane ligand. As seen from Figure 10a, the osmium atom is coordinated by two chelating dithiocarbamate ligands and two carbonyls, the latter being mutually cis. The common feature of 158 [125], 159 [125], 160 [126], 161 [126], 162 [126], and 163 [126], is a CP2S2Si donor set. As exemplified for 158 in Figure 10b, the osmium atom is coordinated by two mutually trans phosphane ligands, a carbonyl, a trisubstituted silicon anion and a chelating dithiocarbamate anion. The molecules in 164 [127], 165 [127], 166 [127], 167 [127], 168 [127], 169 [128], 170 [129], 171 [128], and 172 [128] adopt similar coordination geometries whereby the silicon atoms of the previous series are substituted for tin atoms. An exemplar is 170, shown in Figure 10c, which is notable for having a dinuclear tin substituent.
The remaining crystals feature cluster molecules having three, i.e., 173 [131], 175 [131], and 176 [131] or four, 174 [131] osmium atoms. In 173, Figure 10d, the terminal osmium atoms in a chain of three osmium atoms are each chelated by a dithiocarbamate ligand, with further coordination provided by three carbonyl ligands and the octahedral geometry completed by the central osmium atom; the latter features a C4Os2 donor set. In the tetranuclear cluster of 174, Figure 10e, again each terminal osmium atom is chelated by a dithiocarbamate ligand. The coordination geometry for one of the osmium atoms is based on a C3S3 donor set as three of the osmium atoms are µ3-bridged by a sulfide-S atom while the second terminal osmium atom has a C3OS2 coordination geometry as the µ3-carbon dioxide atom employs all three atoms in coordination to three different osmium atoms. Finally, the osmium atoms of 175 and 176 are arranged in a triangle. As shown for 176 in Figure 10f, the dithiocarbamate ligand forms bonds with each of the osmium atoms, forming a bond to one ring osmium atom and at the same time connects to the other two osmium atoms via the second sulfur atom. The osmium atoms that are bridged by the µ2-sulfur atom are also bridged by a µ2-hydride atom. Thus, there are two distinct coordination geometries, i.e., C3Os2S and C3HOs2S.

3.1.5. Iridium

Iridium dithiocarbamates are commonly seen as the organometallic complexes as presented in Table 6. The iridium complexes are characterized by coordination number six within a distorted octahedral geometry. As with previous precious group elements, a relatively high degree of commonality is noted in the molecular structures, with structural precedents also in existence. The most presented structural motif among the iridium dithiocarbamates is illustrated in Figure 11a for 177 [133]. The iridium atom is chelated by the dithiocarbamate ligand, N,C-chelated by each of two 2-(2-pyridyl)phenyl anions, leading to a C2N2S2 donor set, with trans-nitrogen atoms, which defines an octahedral geometry. Similar structures but with varying substitution patterns in the dithiocarbamate and N,C-chelating ligands are found in the crystals of 178 [134], 179 [135], 180 [136], 181 [136], 182 [136], 183 [137], 184 [137], 185 [137], 186 [27], 187 [138], 188 [139], 189 [139], 190 [139], 191 [140], 192 [138], 193 [140], 194 [141], 195 [142], 196 [143,144], 197 [145], and 198 [146,147].
In crystals of 199 [148], 200 [148], 201 [148], and 202 [148] a C2P2S2 donor set is featured. In neutral 199, Figure 11b, the iridium center is chelated by dithiocarbamate and C,C-chelating (1-(methylsulfanyl)penta-1,4-diene-1,5-diyl ligands with the phosphane molecules occupying mutually trans positions. The complex molecules in 200–202 are cationic and adopt the same structural motif. The remaining iridium dithiocarbamate structures feature Cp* ligands. The cation in 203 [149] has a geometry reminiscent of the ruthenium analog shown in Figure 5c. A new structural motif is noted for the dication in 204 [150]. Each dithiocarbamate ligand chelates one iridium atom and uses one of the sulfur atoms to bridge the adjacent iridium atom. While not crystallographically imposed, the molecule has approximately 2-fold symmetry so the dithiocarbamate ligands lie to the same side of the central Ir2S2 rectangle. In 205 [151], the carbonyl of 203 has been replaced by a 5-methyltetrazolate to give a neutral complex. As noted from Figure 11d, the anion is hydrogen bonded to 5-methyltetrazole in the crystal. In the cation of 206 [151], the hydrogen bonded molecule of 205 is replaced by a [Cp*Ir(L8)] to give the dinuclear molecule shown in Figure 11e. The common feature of 207 [152] and 208 [152] is the coordination by a monodentate dithiocarbamate ligand, rather unusual in the context of the present survey. In 207, Figure 11f, the iridium atom has a C3PS2 donor set with the second sulfur atom derived from a hydrosulfide anion. An intramolecular hydrogen bond is noted between the dithiocarbamate-N–H…S(hydrosulfide) atoms. In 208, another rare example where the dithiocarbamate anion is derived from a primary amine, the hydrosulfide anion of 207 has been replaced by a hydride, Figure 11g. The last iridium structure comprises three independent [Cp*Ir(PPh3)(L25)(NCH3)] cation, and four iodide counterions in the crystal of 209 [153]. The dithiocarbamate cation adopts the structural motif illustrated in Figure 5a.

3.1.6. Platinum

As for the palladium dithiocarbamates, binary structures predominate among the platinum dithiocarbamates which have been characterized by X-ray crystallography, see Table 7 for a listing. Thus, square planar geometries based on S4 donor sets provided by two chelating dithiocarbamates ligands are found in 210 [73], 211 [73], 212 [75,76], 213 [80], 214 [154], 215 [155], 216 [156], 217 [84], 218 [155,157], 219 [157], 220 [158], 221 [159], 222 [160], 223 [161], 224 [86], 225 [162], 226 [163], and 227 [164]. An exemplar molecule is shown for 222 in Figure 12a. This is particularly notable for having additional functionality on the dithiocarbamate ligands giving rise to the possibility of further complexation to other metals. The only binary dithiocarbamate complex that does not conform to the common structural motif is that of 228 [165]. As shown in Figure 12b, the dithiocarbamate ligand carries a pendant pyrazolyl ring and in the case of one dithiocarbamate ligand, a S,N-chelating mode occurs rather than the normal S,S-chelating mode so the resulting donor set is NS3. As alluded to above, the pendent carboxylic acid residues in 228 can be employed in further coordination to generate higher-dimensional aggregation patterns. This possibility has been realized in four crystals, namely 229 [161], 230 [161], 231 [161], and 232 [161]. A one-dimensional coordination polymer results as each L17 ligand is deprotonated at one of the carboxylic acid residues and complexation occurs with one equivalent of Zn(OH2)4. The polymer 229, as in Figure 12c, representative of those in 230 and 231, has a step-like topology. As for 229–231, a square planar geometry based on the S4 donor set is evident for the platinum atom in 232. Here, both carboxylic acid residues of each L52 anion are deprotonated, giving L51. When complexed with two equivalents of Zn(OH2)4, a two-dimensional grid with a flat topology ensues, as illustrated in the plan view of Figure 12d. In all four coordination polymers, the carboxylate ligand is functioning in the monodentate mode.
An unusual pentanuclear structure is found in the crystal of 233 [166]. As indicated in Figure 13a, each dithiocarbamate ligand chelates a platinum atom and simultaneously links to a second platinum via one sulfur atom only. The square planar geometry is completed by a chloride atom. The addition of a phosphane ligand to a binary dithiocarbamate results in one of the dithiocarbamate ligands coordinating in a monodentate mode, as in 234 [26], illustrated in Figure 13b. The bis dithiocarbamate ligand L74 bridges two (PEt3)2Pt entities in dicationic 235 [101], Figure 13c, and a similar structural motif is noted for 236 [101]. In the quaternary complex 237 [167], a ClS3 donor set is defined by the chelating dithiocarbamate ligand, a chloride and a S-bound DMSO molecule, Figure 13d. The complex molecules in 238 [168], 239 [166], 240 [169], 241 [169], 242 [169], and 243 [170], conform to the same structural motif as illustrated for 238 in Figure 13e.
The next series of structures are organoplatinum derivatives starting with the 244 [171] which is readily related to the previous series in that the chloride is now an iodide and the phosphane is replaced by the N-heterocyclic carbene, Figure 14a. The molecules in 245 [172], Figure 14b, 246 [172], and 247 [173] contain C,N-chelating orthometallated species as well as dithiocarbamate. In a variation, doubly orthometallated 2,2′-bipyridyl links two platinum centers in 248 [174], Figure 14c. Figure 14d represents 249 [175] and 250 [176] with CPS2 donor sets. In the final molecular structure to be described, the platinum atom of Figure 14b is linked to Pt(C6F5)2 via two diphenylphosphinato ligands resulting in a rare example of a CNP2S2 donor set in 251 [177], Figure 14e. The last remaining structure to be described is a coordination polymer, i.e., in the crystal of 252 [172]. Here, the platinum atom is C,N-chelated by a benzo[h]quinolin-10-yl ligand with the square planar geometry completed by a chelating dithiocarbamate ligand. The latter is also connected to a silver cation which also forms connections to two platinum atoms to form a one-dimensional coordination polymer.

3.2. Nuclear Magnetic Resonance (NMR) Studies

3.2.1. 1H NMR

Solution 1H NMR data has been reported for dithiocarbamate complexes for all platinum-group metals, with data for palladium(II) and ruthenium(II) complexes predominating. As a consequence of restricted rotation around the carbamoyl C–N bond (see below), it is often the case that the dithiocarbamate ligand substituents give rise to two or, depending on the number of dithiocarbamate ligands and the local symmetry, occasionally more sets of resonances, which can complicate unambiguous assignment of signals, but conversely can also provide a wealth of useful information on the solution-state structures. The α-hydrogen nuclei provide the most characteristic probe. The chemical shifts vary quite significantly and typically range between about 1.80 and 4.5 ppm, depending on both the dithiocarbamate itself and the metal moiety to which it is coordinated. Table 8 shows how the mean chemical shifts and the standard deviation of these shifts varies with metal ion; Figure 15 shows the mean and 95% range (two standard deviations) for the shifts. Note that the data given in Table 8 and Figure 15 for ruthenium(II) are for dimeric complexes which are diamagnetic by virtue of spin pairing between the two ruthenium(II) centers. Although there is much overlap, Figure 15 reveals a clear trend in the mean shifts:
(i)
Decrease down a Group,
(ii)
Increase across a Period,
(iii)
Increase with the oxidation state of the metal ion.
These trends are statistically significant (based on standard two-tailed t-tests).
The 1H NMR chemical shifts of the α-hydrogens are also sensitive to the R-group of R2NCS2−, with those of benzyl groups and alicyclic groups, typically cyclohexyl, resonating at the higher end of the range and those of simply alkyl groups, such as R = Me and Et at the lower end of the range. Thus, for example, in the complexes Pd(S2CNR2)(η3–2-methylallyl), NR2 = NMe2 (L8), N(CH2Ph)2 (L39), and N(Me)Cy (L15), the signals due to α-hydrogens of L39 and L15 are found at 4.92 and 3.7 ppm, respectively, while the NCH3 signals of L8 and L15 lie at 3.33 and 2.08 ppm, respectively [77]. Another comparative example may be found in reference [79]. The α-hydrogen signals of piperazinedithiocarbamate ligands, −S2CN(CH2CH2)2NR, are also generally found in the mid to upper end of the range; as, for example in [(p-tolyl)3PPd(L69)Cl]: 3.60 ppm [110]. Although less common, complexes of dithiocarbamates derived from primary amines have also been studied. Typical examples include Pd(L2)2 [73], Pd(L4)2 [73] and {Me3Pt(L2)}2 [178]. The NH hydrogen signal is found in the range 6.82 to 10.95 ppm. Limited data frustrate attempts to identify any trends in the shifts.
Routinely, NMR spectroscopy is generally restricted to diamagnetic compounds because the presence of unpaired electrons can substantially reduce relaxation times, which can lead to very broad and often featureless spectra. However, paramagnetism also extends the normal chemical shift range, and in so doing can provide useful additional structural information. The rate of relaxation and the chemical shift of a nuclide in the presence of a paramagnetic center are related to the distance from that paramagnetic center. At short separations, the high rates of relaxation broaden the signals to such an extent that they are not detectable, whilst at longer ranges, the effects may be too small to give appreciable effects. Between these limits—the Goldilocks zone—observable, but widely dispersed signals are seen. These signals can be used to infer more detailed information about the structure. Dithiocarbamate complexes of ruthenium(II) are a good example, with the α-hydrogens of the dithiocarbamate, often lying in the Goldilocks zone. 1H NMR data for a series of ruthenium(III) dithiocarbamate complexes are given in Table 9.
In the case of Ru(L8)3, the magnetic moment was calculated from the 1H NMR shifts, using the Evans’ Method [179]. The effective magnetic moment, μeff, was found to be 1.92 μB, at room temperature, consistent with a low-spin d5 electronic configuration: i.e., with a single unpaired electron [25]. For complexes of general formula M(S-S)3 for S-S = dithiocarbamate, there exists the possibility of two isomeric forms, namely L-M(L-L)3 and D-M(S-S)3, Figure 16.
The two isomers are exchanged by inversion at the metal center. In the case of the Ru(III) complexes, both the barrier to inversion and the barrier to rotation about the dithiocarbamate C-N bond (see below) are such that exchange is slow on the NMR time scale at room temperature. Consequently, the NMR spectra in complexes of unsymmetrical dithiocarbamate ligands can be quite complex, with different (C-N) rotational isomers observed for each of the L- and the D-configurations. In the case of Ru(L61)3, for example [180], 12 sets of signals due to the α-hydrogen nuclei are observed in the 1H NMR spectrum in the region 50–20 ppm.
In the majority of cases, the dithiocarbamate ligand is coordinated to the metal center via both sulfur atoms in an essentially symmetric fashion. However, there are examples of where the dithiocarbamate is coordinated via one sulfur atom only. For example, in [Tp*Rh(η2-L24)(η1-L24)] (Tp* = HB(3,5-pyrazol-1-yl)) [68], and [Cp*Rh(η2-L24)(η1-L24)] (Cp* = pentamethylcyclopentadienyl) [181], one of the two diethyldithiocarbamate ligands is symmetrically bound via both S atoms, while the other acts as a monodentate ligand. The different coordination modes are readily distinguished because, in the case of the bidentate bound ligand, the lack of symmetry along the S2C-N bond results in two sets of signals being observed for the ethyl group in the symmetrically bound ligand, but one set for the monodentate bound ligand: the methylene (NCH2) hydrogens appear as a doublet of quartets in the κ2-bound ligand and as a simple quartet in the κ1-bound ligand. In the case of [Cp*Rh(κ2-L24)(κ1-L24)], coalescence of the signals is observed above ca 350 K indicating exchange between the κ2- and κ1-bound ligands [181]: such exchange was not observed in [Tp*Rh(κ2-L24)(κ1-L24)]. One final point to note is that the 1H signals of the dithiocarbamate ligands such as piperazinedithiocarbamate or mono- or dicyclohexyl-dithiocarbmate may also be affected by dynamic phenomena of the ring. Thus, for example, it is not untypical for the piperazine (S2C)NCH2- signals to be broadened by ring flexing [55].
Although agostic interactions between the α-hydrogens of dithiocarbamate ligands, S2CN(R)CH(R′), and the metal center may be observed in the solid-state, such interactions are not generally evident in solution, at least under ambient conditions. Attempts to establish the presence of agostic interactions at lower temperatures have met with mixed success. Thus, for example, 1H NMR of a solution Ni(L40)2, cooled to liquid nitrogen temperatures failed to reveal any evidence of the agostic interactions observed in the crystal structure of the complex [86]. Whereas, for the related palladium(II) complex, Pd(L41)2 for [86], the singlet due to the α-hydrogen nuclei of the CH2C5H4N-3, split into two equally intense signals at 233 K, consistent with one of the methylene hydrogen atoms being involved in an agostic interaction with the metal center. The 1H NMR sub-spectra due to the dithiocarbamate ligand in these complexes can, overall, thus provide a wealth of structural information, and hence be of intrinsic value beyond just routine characterization.

Barrier to C–N Bond Rotation

The significant contribution of resonance form (II) (Figure 1) lends substantial double bond character to the S2C–N bond, restricting rotation to an extent that, where symmetry allows, different rotomeric species are often visible in the NMR spectra at ambient temperature. Thus, for example, in cis-[Os(CO)2(L8)2], although the two dithiocarbamate ligands are equivalent, there is no plane of symmetry aligned along the C–N bond vector, rendering the methyl groups in each ligand inequivalent. Two equally intense signals, each of which integrates to six hydrogens, are observed for the NCH3 groups at ambient temperature. These signals broaden on warming and eventually coalesce at ca 90 °C [130]. Similarly, the methylene protons of {Pd(L13)2} [78] are also inequivalent and, due to the restricted rotation about the C–N bonds are distinguishable in the NMR spectrum. Two doublets, each of integral 2, are observed at 4.75 and 5.21 ppm (2JHH = 7 Hz). Well known as the barrier to rotation is, there remain relatively few studies on the magnitude of that barrier: contemporary data for platinum-group metal complexes are collected in Table 10.
Table 10 also includes a comparison of the C–N stretching frequencies, where available, with the barrier to rotation. This relationship is depicted graphically in Figure 17. Figure 17 shows that the C–N stretching frequencies are very loosely, but never-the-less negatively correlated with higher barriers to C–N bond rotation: higher barriers are more associated with lower C–N stretching frequencies. This is contrary to expectation given that higher barriers should be associated with an increased double bond character, and thence would be expected to correlate with higher C–N stretching frequencies. However, with the very limited data available more inquiry into this relationship would be of value.

3.2.2. 13C NMR

13C NMR data are, unsurprisingly, more sparse than 1H NMR data. The quaternary carbamoyl carbon atom, S2CNR2, is most characteristic, although it is not always observed because of its long relaxation times. For the compounds discussed in this review, shifts typically range between ca 200 and 215 ppm (mean ca 208 ppm) and, compared to the corresponding signal in the free ligand, is typically shifted to a lower frequency by around 5 ppm, due to a reduction in the delocalization in the S2C–N system (i.e., increases the contribution of structures I and III, Figure 1). As would logically be expected, since coordination reduces delocalization, the νC–N bond stretching in the infrared, which is normally in the range 1320–1600 cm−1, generally increases on coordination [183]. Whilst the carbamoyl moiety provides the most-ready probe for confirming metal complexation, the wider dispersion of 13C chemical shifts, as compared to those of 1H, mean that the 13C signals of the nitrogen substituents, S2CNR2, are also of utility. The 13C NMR shifts of the N-alkyl substituent groups are to be found in the region 12–55 ppm, with those attached directly to the N-atom (α-C) found at the high-frequency end of this range: 45–55 ppm; while β- and γ-carbon nuclides are typically in the ranges 20–30 and 12–20 ppm, respectively. These distinct chemical shift ranges make the assignment of the 13C NMR spectra of alkyl-substituted dithiocarbonate complexes a relatively straightforward and unambiguous process. The 13C NMR shifts of N-aryl substituent groups are, as would be expected, less well separated and typically observed in the region 120–150 ppm: Cipso 130–160 ppm; Cortho 122–132 ppm; Cmeta 125–130 ppm; Cpara 120–135 ppm.
Solid-state NMR (SSNMR) studies, usually 13C CP-MAS, have been reported for a number of complexes [98,164,175]. Unsurprisingly, the SSNMR spectra are generally more complex than the corresponding solution NMR spectra because the three-dimensional crystalline environment effectively reduces the symmetry of the molecules. Thus, for example, the 13C CP-MAS SSNMR spectrum of Pt(L80)2 reveals the dithiocarbamate ligands to be inequivalent in the solid-state; the carbamoyl carbon atoms (S2CN<) give rise to a 1:5:5:1 pseudo-quartet at ca 209.6 ppm, resulting from overlapping 1:4:1 triplets (the triplet fine structure arises from coupling to 195Pt: I = ½; 33.8% abundance), whereas in solution a single signal is observed [164]. The same patterns are observed in the solid-state 13C spectra of Pt(L29)2 and Pt(L34)2 [155]. Although the symmetry is lower in the solid-state, it is clear that the basic molecular structure is the same in the solid-state and solution in these complexes. Likewise, the structure of silica-supported [Pd(Ph2P(CH2)3PPh2)(L24)]BF4 has been shown by SSNMR to be largely unaffected, compared to the solution structure [98].

3.2.3. 195Pt NMR

195Pt NMR data are available for some platinum(II) and platinum(IV) dithiocarbamate complexes. Data are collated in Table 11.
For the platinum(II) complexes, the chemical shifts range from 603 to 810 ppm, as compared to 1416 to 1632 ppm for the platinum(IV) complexes. The higher chemical shifts of the platinum(IV) complexes are consistent with the general observation that the resonance frequency increases with the oxidation state [184]. Similarly, the trend to a higher frequency in the platinum(II) complexes on ionization (removal of H+) is consistent with the higher charge at the metal center.

3.3. Applications

3.3.1. Biological Applications

Perhaps unsurprisingly, one of the most common areas of the potential application of dithiocarbamate complexes to be explored is that related to their anti-cancer properties. Ever since cisplatin, cis-[PtCl2(NH3)2], was first approved for use in the treatment of testicular and ovarian cancers by the US food and Drug Administration in 1978 [185], the chemotherapeutic applications of platinum and, more generally, platinum group metal compounds have been the subject of ongoing investigation. Given that organic derivatives of dithiocarbamates, RSC(S)NR′2, also display antitumor activity [186], the exploration of anti-cancer properties of platinum-group metal dithiocarbamate complexes is an obvious avenue for research [187].
The half-maximal inhibitory concentration, IC50, is a commonly used measure of the effectiveness of a compound at inhibiting a particular biological function, such as cell proliferation. The in vitro cytotoxicities of those platinum-group metal complexes described in this review against various human cancer cell lines are given in Table 12. Given that the effectiveness of complexes has been investigated against a variety of different cell lines and with many experiments conducted under different laboratory conditions, it is hard to draw general conclusions from the data. Where a common cell line has been used (HeLa; cervical cancer cell line), data indicate that the ruthenium complexes are significantly more active (lower IC50) than either palladium or platinum. The sparse data and diversity of cell lines used in reported cases suggest that some more systematic studies on the antitumor activity of platinum group metal dithiocarbamate complexes would add significantly to the body of literature.
DNA binding studies have also been carried out to explore the mechanism of the antitumor activity. The DNA binding of complexes of general formula (PR3)Pd(S2CNR2)Cl, PR3 = PPh3, PPh2Cl, PPh2(tert-Bu), PPh2(CH2Ph), PPh2(o-tolyl), PPh2(p-tolyl), PPh2(C6H4OMe-o); R = Me (L8), Et (L24), n-Pr (L28), n-Bu (L31), 2-methoxyethyl (L26), have been probed by cyclic voltammetry [103,115]. The cyclic voltammograms of the complexes display a single cathodic peak due to an irreversible one-electron reduction of the complexes. The addition of DNA more normally causes a diminution in the cathodic peak height and may also induce a shift in the position of the peak, consistent with DNA binding. In some complexes, DNA binding has been shown to lead to increased cathodic peak height, indicating DNA may also catalyze the electron transfer process [103]. Binding constants [103] were found to be in the range 6.16 × 102–7.05 × 106 M−1, with the corresponding free energies of activation being in the range −16 to −39 kJ mol−1. The greatest binding affinity was found for [PPh2(p-tolyl)Pd(L31)2}(Cl)] and was attributed to the presence of the hydrophobic butyl groups on the dithiocarbamate.
UV-Vis spectroscopy also provides a readily accessible probe for DNA binding studies. The UV-vis spectra typically display bands in the region 220–460 nm, attributable to both charge transfer (CT: metal-to-ligand and ligand-to-metal), intraligand π→ π* and metal centered d-d transitions. The CT bands are distinguishable because of their high molar extinction coefficients [25,180]. The addition of increasing concentrations of DNA leads to a decrease in absorption peak intensity, from which the free energies of interaction can be calculated, with complex-specific negative values indicating spontaneous interaction between the DNA and the complexes [109,188,189]. In general, the DNA-complex appears to be stable over a prolonged period (at least 48 h). For further information, the interested reader is referred to [190,191,192,193,194] being reviews of platinum group dithiocarbamates and anti-cancer potential.
Although less well studied than their anti-cancer properties, platinum group metal dithiocarbamate complexes are also known to exhibit antifungal properties. The antifungal properties of the palladium(II) and platinum(II) complexes M[S2CN(Me)R]2, where R = 2,3-dimethoxyethyl (L16) or 1,3-doxolane-2-methyl (L23), have been reported [80]. All four complexes were found to be active against A. flavus, A. niger, and A. parasiticus: the complexes are more active than the drug Nyastin, but less active than miconazole nitrate, which is known to display extensive biocide action. In general, the palladium complexes displayed similar or greater activity. In the case of the palladium complexes, those of L23 were generally more active, whereas in the platinum complexes, those of L16 were more active [80]. These preliminary studies suggest that the antifungal behavior of platinum-group metal dithiocarbamate complexes would warrant further study.
Another potential application offered by dithiocarbamates being their use as an antibacterial agent, as shown by the inhibitory effect of pyrrolidine dithiocarbamate against bacterial strains P. gingivalis, A. actinomycetemcomitans, S. aureus, and E. coli and the enhanced activities resulted from the coadministration of ZnCl2 [195,196]. Significantly more investigations have been performed on the antibacterial potential of heavy element dithiocarbamate compounds with the area being reviewed very recently [197]. Among which, a series of six heteroleptic palladium(II) dithiocarbamates of general formula (PR3)Pd(S2CNR2)Cl, PR3 = PCy3, PPh2(CH2Ph), PPh2(C5H4N-2), PPh2(m-tolyl), PPh2(p-tolyl), PPh2(C6H4OMe-o); R = Me (L8), Et (L24), 2-methoxyethyl (L26) and Cy(L47) demonstrated antibacterial potency against two Gram-negative (E. coli and K. pneumoniae) and three Gram-positive bacterial strains (S. epidermidis, S. aureus, and B. subtilis) [117]. The above study further suggested dithiocarbamates of increased lipophilicity presented improved efficacy owing to the better permeability through the cell membrane of the bacterium.
Table
Table 12. In vitro cytotoxicity of platinum-group metal dithiocarbamate complexes.
Table 12. In vitro cytotoxicity of platinum-group metal dithiocarbamate complexes.
Complex aIC50/μM bRef.
LUMCF7Heap-1c1c7PC-3MDA-MB-231HepG2/CTRHepG2/SB3HeLaHL60DaudiLoVoA549HTB-81MRC-5
β-[Ru2(L57)5]Cl -----0.62(0.08)0.59(0.01)0.45(0.02)------[180]
β-[Ru2(L63)5]Cl -----0.66(0.01)0.75(0.02)0.46(0.04)------[180]
β-[Ru2(L60)5]Cl -----9.2(2)>103.95(0.07)------[180]
β-[Ru2(L61)5]Cl -----1.28(0.05)0.90(0.02)0.27(0.01)------[180]
[PPh3Ru(η1-ClL)(CO)(L57)] ----≈25---------[56]
[PPh2(p-tolyl)Pd(L69)Cl] 25.03(6.4)26.9(4.1)22.6(3.0)18.4(2.8)19.4(1.1)---------[110]
3.726.205.46[109]
[P(p-tolyl)3Pd(L69)Cl] 32.9(1.8)25.2(0.1)36.9(5.1)38.4(1.2)29.5(2.0)---------[110]
5.185.295.76[109]
[PPh2(p-tolyl)Pd(L76)Cl] 5.6(0.4)0.01(0.005)0.1(0.2)1.3(2.2)2.8(1.2)---------[110]
[P(p-tolyl)3Pd(L76)Cl] 2.9(0.1)2.21(3.5)12.2(1.9)15.0(3.9)7.1(1.9)---------[110]
[PPh2(p-tolyl)Pd(L78)Cl] 10.57(2.4)2.4(1.0)10(3)33.6(2.9)5.4(4.1)---------[110]
[P(p-tolyl)3Pd(L78)Cl] 10(2.4)3.02(0.3)2.8(0.4)3.9(0.024)7.0(3.6)---------[110]
[PPh2(p-tolyl)Pd(L67)Cl] -4.51-5.11-------4.83--[109]
[P(p-tolyl)3Pd(L67)Cl] -4.12-7.12-------7.21--[109]
[PPh2(CH2Ph)Pd(L24)Cl] ------------3.67-[114]
[PPh2(tert-But)Pd(L31)Cl] ------------9.52-[115]
[PPh2(CH2Ph)Pd(L28)Cl] ------------4.57-[115]
[PPh2(Cl)Pd(L28)Cl] ------------21.7-[115]
[PPh3Pd(L26)Cl] ------------2.12-[115]
[PPh2(tert-But)Pd(L38)Cl] -------------36.7(2.9)[117]
[PPh2(nPr)Pd(L26)Cl] ------------->100[117]
[PPh3Pd(L36)Cl] -------------71.5(13.1)[117]
[PPh3Pd(L35)Cl] ------------->100[117]
[PPh3Pd(L37)Cl] -------------81.6(13.1)[117]
[PPh2(p-tolyl)Pd(L36)Cl] -------------22.8(2.4)[117]
[PPh2(p-tolyl)Pd(L35)Cl] ------------->100[117]
[PPh2(p-tolyl)Pd(L38)Cl] -------------30.8(2.6)[117]
[PPh2(CH2Ph)Pd(L38)Cl] ------------->100[117]
[PPh3Pd(L38)Cl] -------------65.3(12.5)[117]
[Pd(3-pic)(L20)Cl] ------->100>100>100>100---[198]
[Pd(2-pic)(L20)Cl] -------69.54(0.31)59.62(0.54)97.12(1.93)53.24(1.52)---[198]
[Pt(3-pic)(L20)Cl] -------98.90(2.33)>100>100>100---[198]
[Pt(2-pic)(L20)Cl] -------9.32(1.22)39.12(1.33)45.22(1.21)25.32(2.02)---[198]
a ClL = 3-[(p-Chlorophenylimino)methyl]-4-cresol; pic = picoline. b By 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay; Standard deviation given in parentheses.

3.3.2. Other Applications

Besides their biological behavior, platinum-group dithiocarbamate complexes have potential utility as metal ion sensors [142,190], as single-source precursors for MOCVD [77], and as catalysts. Cyclometalated iridium(III) dithiocarbamate complexes of the type [Ir(dpci)2(S2CNR2)], where dpci = 3,4-diphenylcinnoline; NR2 = NEt2 (L24) and N-carbazolyl (L82) are both highly selective and highly sensitive mercury chemosensors [142,190]. The sensors work by having a photoluminescent complex, with a relatively labile dithiocarbmate ligand, which can be scavenged by Hg2+ ions; the ideal scenario is that the presence of the Hg2+ ions act as a clear “on” switch, and these complexes display just such behavior. Furthermore, the complex [Ir(dpci)2(L82)] can operate as an AND logic gate, both changing color and displaying significant photophorescence in the presence of acetonitrile (which causes the color change) and Hg2+ ions [142].
Metal dithiocarbamate complexes are well-known as potential single-source precursors for the deposition of metal sulfide thin films [199,200]. The complexes [Pd(allyl)(S2CNR2)], with NR2 = NMe2 (L8), NEt2 (L24), N(nPr)2 (L28), N(nBu)2 (L31), N(CH2Ph)2 (L39), N(Me)Bu (L11), N(Me)Hex (L12), and NC5H10 (L61), may be used as single-source precursors for the MOCVD of PdxSy thin films. In particular, [Pd(allyl)(L12)], was shown to produce films comprising Pd3S, Pd4S, Pd2.2S, Pd2.5S, and, predominately, Pd2.8S at 350 °C [77]. The composition of such films may well be temperature-dependent [201]. Finally, in relation to complexes pertinent to this review, some ruthenium(II) dithiocarbamate complexes, namely [Ru(dppb)(S2CNR2)2] (dppb = 1,4-bis(diphenylphosphino)butane; NR2 = NEt2 (L24), NC5H10 (L63), N(CH2CH2)2O (L79), and N(cyclohexyl)) (L80) have been demonstrated to be pre-catalysts for the epoxidation of cis-cyclooctene, with conversation rates of ca 50–60%, using PhIO as the oxidant [34]. The mechanism appears to involve loss of the dppb ligand to form a Ru=O species. The dithiocarbamate ligands help to promote the displacement of dppb fostering the formation of the catalytic species, with both steric and electronic factors in play.

4. Conclusions

In summary, dithiocarbamates are highly versatile ligands, which are found in a wide variety of platinum group (and other) metal complexes. The resultant metal dithiocarbamate moiety may itself be the locus chemical or structural interest, or it may be that it is present in an ancillary capacity. The pendant organic groups on the dithiocarbamate nitrogen atom can be as varied as those on the parent amines, from which they are derived, allowing fine-tuning of both the electronic and steric environment around the ligand and hence of the structural and electronic properties of the complexes. The resultant platinum group metal complexes have been shown to have a variety of applications, with their anticancer properties being the most well studied. Comparison of X-ray structural data with NMR for these complexes indicates that the molecular structures are essentially the same in both the solid-state and in solution. Solution NMR, in particular, provides an excellent probe for metal-dithiocarbamate coordination, with the carbamoyl C atom and the α-hydrogen atoms of the N substituents resonating at characteristic frequencies. Given their facile preparation, considerable stability and versatility in coordination chemistry, it is highly likely that the interest in these compounds will continue to grow.

Author Contributions

Writing—original draft preparation, review, and editing, Y.S.T.; Writing—original draft preparation, review, and editing, C.I.Y.; Writing—original draft preparation, review, and editing, E.R.T.T.; Conceptualization, writing—original draft preparation, review, and editing, P.J.H. All authors have read and agreed to the published version of the manuscript.

Funding

Research in dithiocarbamate chemistry at Sunway University is funded by Sunway University Sdn Bhd, grant number GRTIN-IRG-01–2021. The APC was funded by Sunway University Sdn Bhd.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

bmi1-benzyl-3-methyl-imidazole
bpy 2,2′-bipyridine
btfmppy 2-(2,4-bis(trifluoromethyl)-phenyl)pyridine
buppy2-(4′-tert-butylphenyl)pyridine)
bzqbenzo(h)quinoline
C≡CBMIDA C≡CB(O2CCH2)2NMe
cyclam 1,4,8,11-tetraazacyclotetradecane
depe1,2-bis(diethylphosphino)ethane
dmbp 4,4′-dimethyl-2,2′-bipyridine
dmsodimethylsulfoxide
dpci3, 4-diphenylcinnoline
dpp4,6-diphenyl pyrimidine
dppb1,4-bis(diphenylphosphino)butane
dppe1,2-bis(diphenylphosphino)ethane
dppf1,1′-bis(diphenylphosphino)ferrocene
dppm1,1-bis(diphenylphosphino)methane
dppp1,3-bis(diphenylphosphino)propane
fcdpm 5-Ferrocenyl dipyrromethene
mtz5-methyltetrazole
pba4-(2-pyridyl)benzaldehyde
pbt2-phenylbenzothiazole
p-cymene 1-isopropyl-4-methylbenzene
phpy2-phenylpyridine
phpzn-phenylpyrazole
pmea2-metallated 3-perylmethylen-4′-ethylaniline
ppy2-phenylpyridine
pqz4-phenylquinazoline
ptbt2-(p-tolyl)benzothiazole
pyrpyrimidine
tfmbpy2′,6′-bis(trifluoromethyl)-2,4′-bipyridine
tfmpiq 1-(4-(trifluoromethyl)phenyl)-isoquinoline
tfmppy2-(4-(trifluoromethyl)phenyl)pyridine
tfmpqz4-(4-(trifluoromethyl)phenyl)quinazoline
tmedaN,N,N′,N′-Tetramethylethane-1,2-diamine
Tp*HB(3,5-dimethylpyrazol-1-yl)3
tptz2,4,6-tris(2-pyridyl)pyrazine-N,N′,N″
X3-(((4-chlorophenyl)imino)methyl)-2-hydroxy-5-methylphenyl
X1η3, η3–2,7-dimethylocta-1,6-dien-3,8-diyl
X21,2-bis(2-phenylethynylmethylene)cyclohexane
X3 Inorganics 09 00060 i001
X42,5-di-p-tolyl-1,3,4-oxadiazole
X53-perylenylmethylen-4′-ethylaniline

References

  1. Coucouvanis, D. The chemistry of the dithioacid and 1,1-dithiolate complexes. In Progress in Inorganic Chemistry; Lippard, S.J., Ed.; John Wiley & Sons: Hoboken, NJ, USA, 1970; Volume 11, pp. 234–371. [Google Scholar] [CrossRef]
  2. Eisenberg, R. Structural systematics of 1,1- and 1,2-dithiolato chelates. In Progress in Inorganic Chemistry; Lippard, S.J., Ed.; John Wiley & Sons: Hoboken, NJ, USA, 1970; Volume 12, pp. 295–369. [Google Scholar] [CrossRef]
  3. Coucouvanis, D. The chemistry of the dithioacid and 1,1-dithiolate complexes, 1968–1977. In Progress in Inorganic Chemistry; Lippard, S.J., Ed.; John Wiley & Sons: Hoboken, NJ, USA, 1979; Volume 26, pp. 301–469. [Google Scholar] [CrossRef]
  4. Hogarth, G. Transition metal dithiocarbamates: 1978–2003. In Progress in Inorganic Chemistry; Karlin, K.D., Ed.; John Wiley & Sons: Hoboken, NJ, USA, 2005; Volume 53, pp. 71–561. [Google Scholar] [CrossRef]
  5. Heard, P.J. Main group dithiocarbamate complexes. In Progress in Inorganic Chemistry; Karlin, K.D., Ed.; John Wiley & Sons: Hoboken, NJ, USA, 2005; Volume 53, pp. 1–69. [Google Scholar] [CrossRef]
  6. Tiekink, E.R.T. Aggregation patterns in the crystal structures of organometallic Group XV 1,1-dithiolates: The influence of the Lewis acidity of the central atom, metal- and ligand-bound steric bulk, and coordination potential of the 1,1-dithiolate ligands upon supramolecular architecture. CrystEngComm 2006, 8, 104–118. [Google Scholar] [CrossRef]
  7. Tiekink, E.R.T.; Zukerman-Schpector, J. Stereochemical activity of lone pairs of electrons and supramolecular aggregation patterns based on secondary interactions involving tellurium in its 1,1-dithiolate structures. Coord. Chem. Rev. 2010, 254, 46–76. [Google Scholar] [CrossRef]
  8. Tiekink, E.R.T. Exploring the topological landscape exhibited by binary zinc-triad 1,1-dithiolates. Crystals 2018, 8, 292. [Google Scholar] [CrossRef] [Green Version]
  9. Tiekink, E.R.T. Perplexing coordination behaviour of potentially bridging bipyridyl-type ligands in the coordination chemistry of zinc and cadmium 1,1-dithiolate compounds. Crystals 2018, 8, 18. [Google Scholar] [CrossRef] [Green Version]
  10. Lee, S.M.; Tiekink, E.R.T. A structural survey of poly-functional dithiocarbamate ligands and the aggregation patterns they sustain. Inorganics 2021, 9, 7. [Google Scholar] [CrossRef]
  11. Tiekink, E.R.T. On the coordination role of pyridyl-nitrogen in the structural chemistry of pyridyl-substituted dithiocarbamate ligands. Crystals 2021, 11, 286. [Google Scholar] [CrossRef]
  12. Masui, H. Metalloaromaticity. Coord. Chem. Rev. 2001, 219–221, 957–992. [Google Scholar] [CrossRef]
  13. Tiekink, E.R.T.; Zukerman-Schpector, J. Emerging supramolecular synthons: C–H⋯π(chelate) interactions in metal bis(1,1-dithiolates). Chem. Commun. 2011, 47, 6623–6625. [Google Scholar] [CrossRef]
  14. Tiekink, E.R.T. The remarkable propensity for the formation of C–H⋯π(chelate ring) interactions in the crystals of the first-row transition metal dithiocarbamates and the supramolecular architectures they sustain. CrystEngComm 2020, 22, 7308–7733. [Google Scholar] [CrossRef]
  15. Sredojević, D.; Bogdanović, G.A.; Tomić, Z.D.; Zarić, S.D. Stacking vs. CH–π interactions between chelate and aryl rings in crystal structures of square-planar transition metal complexes. CrystEngComm 2007, 9, 793–798. [Google Scholar] [CrossRef]
  16. Tan, Y.S.; Halim, S.N.A.; Molloy, K.C.; Sudlow, A.L.; Otero-de-la-Roza, A.; Tiekink, E.R.T. Persistence of C–H⋯π(chelate ring) interactions in the crystal structures of Pd(S2COR)2. The utility of Pd(S2COR)2 as precursors for palladium sulphide materials. CrystEngComm 2016, 18, 1105–1117. [Google Scholar] [CrossRef]
  17. Tiekink, E.R.T. Supramolecular assembly based on “emerging” intermolecular interactions of particular interest to coordination chemists. Coord. Chem. Rev. 2017, 345, 209–228. [Google Scholar] [CrossRef] [Green Version]
  18. Shinde, S.D.; Sakla, A.P.; Shankaraiah, N. An insight into medicinal attributes of dithiocarbamates: Bird’s eye view. Bioorg. Chem. 2020, 105, 104346. [Google Scholar] [CrossRef] [PubMed]
  19. Buac, D.; Schmitt, S.; Ventro, G.; Kona, F.R.; Dou, Q.P. Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells. Mini Rev. Med. Chem. 2012, 12, 1193–1201. [Google Scholar] [CrossRef] [Green Version]
  20. Nagy, E.M.; Ronconi, L.; Nardon, C.; Fregona, D. Noble metal-dithiocarbamates precious allies in the fight against cancer. Mini Rev. Med. Chem. 2012, 12, 1216–1229. [Google Scholar] [CrossRef]
  21. Hogarth, G. Metal-dithiocarbamate complexes: Chemistry and biological activity. Mini Rev. Med. Chem. 2012, 12, 1202–1215. [Google Scholar] [CrossRef]
  22. Ahmed, A.J. Metal complexes of dithiocarbamate derivatives and its biological activity. Asian J. Chem. 2018, 30, 2595–2602. [Google Scholar] [CrossRef]
  23. Sarker, J.C.; Hogarth, G. Dithiocarbamate complexes as single source precursors to nanoscale binary, ternary and quaternary metal sulfides. Chem. Rev. 2021, 121, 6057–6123. [Google Scholar] [CrossRef] [PubMed]
  24. Lewis, E.; Haigh, S.; O’Brien, P. The synthesis of metallic and semiconducting nanoparticles from reactive melts of precursors. J. Mater. Chem. A 2014, 2, 570–580. [Google Scholar] [CrossRef] [Green Version]
  25. Nagy, M.; Nardon, C.; Giovagnini, L.; Marchiò, L.; Trevisan, A.; Fregona, D. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: Systematic solution studies. Dalton Trans. 2011, 40, 11885–11895. [Google Scholar] [CrossRef] [PubMed]
  26. Almazahreh, L.; El-khateeb, M.; Harb, M.; Görls, H.; Weigand, W. Synthesis and characterization of platinum and palladium pyrrolidinedithiocarbamate complexes. Transit. Met. Chem. 2013, 38, 377–383. [Google Scholar] [CrossRef]
  27. Mei, Q.; Shi, Y.; Hua, Q.; Tong, B. Phosphorescent chemosensor for Hg2+ based on an iridium(iii) complex coordinated with 4-phenylquinazoline and carbazole dithiocarbamate. RSC Adv. 2015, 5, 74924–74931. [Google Scholar] [CrossRef]
  28. Batsanov, A.S.; Churakov, A.V.; Howard, J.A.K.; Hughes, A.K.; Johnson, A.L.; Kingsley, A.J.; Neretin, I.S.; Wade, K. Transition metal dicarbollide complexes: Synthesis, molecular, crystal and electronic structures of [M(C2B9H11)(NMe2)3] (M = Nb or Ta) and their insertion reactions with CO2 and CS2. J. Chem. Soc. Dalton Trans. 1999, 3867–3875. [Google Scholar] [CrossRef]
  29. Taylor, R.; Wood, P.A. A million crystal structures: The whole is greater than the sum of its parts. Chem. Rev. 2019, 119, 9427–9477. [Google Scholar] [CrossRef]
  30. Bruno, I.J.; Cole, J.C.; Edgington, P.R.; Kessler, M.; Macrae, C.F.; McCabe, P.; Pearson, J.; Taylor, R. New software for searching the Cambridge Structural Database and visualizing crystal structures. Acta Crystallogr. Sect. B Struct. Sci. Cryst. Eng. Mater. 2002, 58, 389–397. [Google Scholar] [CrossRef]
  31. Brandenburg, K.; Berndt, M. DIAMOND, Version 3.2k; GbR: Bonn, Germany, 2006. [Google Scholar]
  32. Nagy, E.M.; Pettenuzzo, A.; Boscutti, G.; Marchi, L.; Via, L.D.; Fregona, D. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer. Chem. Eur. J. 2012, 18, 14464–14472. [Google Scholar] [CrossRef] [PubMed]
  33. Wu, F.-H.; Liu, Y.-L.; Duan, T.; Lu, L.; Zhang, Q.-F.; Leung, W.-H. Synthesis, structure and electrochemistry of [Ru2(S2CNMe2)3(µ3-S2CNMe2)2]2[Mo6O19]·2CH3COCH3. Z. Naturforsch. B Chem. Sci. 2009, 64, 800–804. [Google Scholar] [CrossRef]
  34. Santos, K.; Dinelli, L.R.; Bogado, A.L.; Ramos, L.A.; Cavalheiro, É.T.; Ellena, J.; Castellano, E.E.; Batista, A.A. Crystal structure and catalytic activity of ruthenium (II)/dithiocarbamate complexes in the epoxidation of cyclooctene. Inorg. Chim. Acta 2015, 429, 237–242. [Google Scholar] [CrossRef]
  35. Pinheiro, S.O.; de Sousa, J.R.; Santiago, M.O.; Carvalho, I.M.M.; Silva, A.L.R.; Batista, A.A.; Castellano, E.E.; Ellena, J.; Moreira, I.S.; Diogenes, I.C.N. Synthesis, characterization and structure of ruthenium(II) phosphine complexes with N-heterocyclic thiolate ligands. Inorg. Chim. Acta 2006, 359, 391–400. [Google Scholar] [CrossRef]
  36. Ng, S.; Ziller, J.W.; Farmer, P.J. Multiple pathways for the oxygenation of a ruthenium(II) dithiocarbamate complex: S-oxygenation and S-extrusion. Inorg. Chem. 2004, 43, 8301–8309. [Google Scholar] [CrossRef] [PubMed]
  37. Cookson, J.; Vickers, M.S.; Paul, R.L.; Cowley, A.R.; Beer, P.D. Amide functionalised dithiocarbamate ruthenium(II) bis-bipyridyl receptors: A new class of redox-responsive anion sensor. Inorg. Chim. Acta 2008, 361, 1689–1698. [Google Scholar] [CrossRef]
  38. Milsmann, C.; Bill, E.; Weyhermuller, T.; George, S.D.; Wieghardt, K. Electronic structures of [RuII(cyclam)(Et2dtc)]+, [Ru(cyclam)(tdt)]+, and [Ru(cyclam)(tdt)]2+: An X-ray absorption spectroscopic and computational study (tdt = toluene-3,4-dithiolate; Et2dtc = N,N-diethyldithiocarbamate(1-)). Inorg. Chem. 2009, 48, 9754–9766. [Google Scholar] [CrossRef] [PubMed]
  39. Hurtubise, V.L.; McArdle, J.M.; Naeem, S.; Toscani, A.; White, A.J.P.; Long, N.J.; Wilton-Ely, J.D.E.T. Multimetallic complexes and functionalized nanoparticles based on unsymmetrical dithiocarbamate ligands with allyl and propargyl functionality. Inorg. Chem. 2014, 53, 11740–11748. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Naeem, S.; Ogilvie, E.; White, A.J.P.; Hogarth, G.; Wilton-Ely, J.D.E.T. The functionalisation of ruthenium(II) and osmium(II) alkenyl complexes with amine- and alkoxy-terminated dithiocarbamates. Dalton Trans. 2010, 39, 4080–4089. [Google Scholar] [CrossRef] [PubMed]
  41. Wilton-Ely, J.D.E.T.; Solanki, D.; Hogarth, G. Multifunctional dithiocarbamates as ligands towards the rational synthesis of polymetallic arrays: An example based on a piperizine-derived dithiocarbamate ligand. Eur. J. Inorg. Chem. 2005, 2005, 4027–4030. [Google Scholar] [CrossRef]
  42. Knight, E.J.; Cowley, A.R.; Hogarth, G.; Wilton-Ely, J.D.E.T. Bifunctional dithiocarbamates: A bridge between coordination chemistry and nanoscale materials. Dalton Trans. 2009, 607–609. [Google Scholar] [CrossRef]
  43. Wu, F.-H.; Duan, T.; Lu, L.; Zhang, Q.-F.; Leung, W.-H. Synthesis and reactivity of ruthenium complexes with 1,1′-dithiolate ligands. J. Organomet. Chem. 2009, 694, 3844–3851. [Google Scholar] [CrossRef]
  44. Wu, F.-H.; Duan, T.-K.; Lu, L.-D.; Zhang, Q.-F. Syntheses and structures of two ruthenium(III) complexes [Ru(PPh3)2(S2CNR2)Cl2]·CH2Cl2(R=Et and iPr). Chin. J. Struct. Chem. 2010, 29, 23–28. [Google Scholar]
  45. Sharma, S.; Chandra, M.; Pandey, D.S. New multifunctional complexes [Ru(κ3-L)(EPh3)2Cl]+ [E = P, As; L = 2,4,6-Tris(2-pyridyl)-1,3,5-triazine] containing both group V and polypyridyl ligands. Eur. J. Inorg. Chem. 2004, 2004, 3555–3563. [Google Scholar] [CrossRef]
  46. Deeming, A.J.; Forth, C.; Hogarth, G. Reactions of trans-[RuCl2(CO)2(PEt3)2] with 1,1-dithiolates: Stepwise formation of cis-[Ru(CO)(PEt3)(S2X)] (X = CNMe2, CNEt2, COEt, P(OEt)2, PPh2). J. Organomet. Chem. 2006, 691, 79–85. [Google Scholar] [CrossRef]
  47. Boyd, P.D.W.; Hart, M.C.; Pritzwald-Stegmann, J.R.F.; Roper, W.R.; Wright, L.J. Selective substitution of one of the substituents on germanium in coordinatively unsaturated ruthenium germyl complexes. Organometallics 2012, 31, 2914–2921. [Google Scholar] [CrossRef]
  48. Kwok, W.-H.; Lu, G.-L.; Rickard, C.E.F.; Roper, W.R.; Wright, L.J. Tethered silyl complexes from nucleophilic substitution reactions at the Si–Cl bond of the chloro(diphenyl)silyl ligand in Ru(SiClPh2)(κ2-S2CNMe2)(CO)(PPh3)2. J. Organomet. Chem. 2004, 689, 2979–2987. [Google Scholar] [CrossRef]
  49. McQueen, C.M.A.; Hill, A.F.; Sharma, M.; Singh, S.K.; Ward, J.S.; Willis, A.C.; Young, R.D. Synthesis and reactivity of osmium and ruthenium PBP–LXL boryl pincer complexes. Polyhedron 2016, 120, 185–195. [Google Scholar] [CrossRef]
  50. Wang, X.-Y.; Shi, H.-T.; Zhang, Q.-F. Synthesis and structure of a ruthenium(II)-dithiocarbamate complex [RuH(CO)(PPh3)2(4-CIPhNHCS2)]·C6H14. Chin. J. Struct. Chem. 2011, 30, 470–473. [Google Scholar]
  51. Toscani, A.; Heliövaara, E.K.; Hena, J.B.; White, A.J.P.; Wilton-Ely, J.D.E.T. Multimetallic alkenyl complexes bearing macrocyclic dithiocarbamate ligands. Organometallics 2015, 34, 494–505. [Google Scholar] [CrossRef]
  52. Hill, A.F.; Stewart, C.D.; Ward, J.S. Organometallic chemistry of ethynyl boronic acid MIDA ester, HC [triple bond, length as m-dash] CB (O 2 CCH 2) 2 NMe. Dalton Trans. 2015, 44, 5713–5726. [Google Scholar] [CrossRef] [PubMed]
  53. Naeem, S.; White, A.J.P.; Hogarth, G.; Wilton-Ely, J.D.E.T. Multifunctional dithiocarbamates: Synthesis and ring-closing metathesis of diallyldithiocarbamate complexes. Organometallics 2010, 29, 2547–2556. [Google Scholar] [CrossRef]
  54. Bartlett, M.J.; Frogley, B.J.; Hill, A.F.; Sharma, M.; Smith, M.K.; Ward, J.S. Hydrogenating an organometallic carbon chain: Buten-yn-diyl (CH=CHC≡C) as a missing link. Dalton Trans. 2019, 48, 16534–16554. [Google Scholar] [CrossRef] [PubMed]
  55. Macgregor, M.J.; Hogarth, G.; Thompson, A.L.; Wilton-Ely, J.D.E.T. Multimetallic arrays: Symmetrical and unsymmetrical bi-, tri-, and tetrametallic organometallic complexes of ruthenium(II) and osmium(II). Organometallics 2009, 28, 197–208. [Google Scholar] [CrossRef]
  56. Ghosh, M.K.; Mandal, S.; Mohapatra, S.; Chatterjee, A.; Bhattacharyya, A.; Chattopadhyay, S. Spectroscopic, structural, electrochemical, and cytotoxicity studies on dithiocarbamato-chelated ruthenium organometallics incorporating imine-phenol function. J. Coord. Chem. 2019, 72, 180–200. [Google Scholar] [CrossRef]
  57. Ollivier, A.; Foresti, R.; El Ali, Z.; Martens, T.; Kitagishi, H.; Motterlini, R.; Rivard, M. Design and biological evaluation of manganese- and ruthenium-based hybrid CO-RMs (HYCOs). ChemMedChem 2019, 14, 1684–1691. [Google Scholar] [CrossRef] [PubMed]
  58. Hogarth, G.; Faulkner, S. Cyclopentadienyl ruthenium(II) dithiocarbamate complexes: Crystal structures of [CpRu(PPh3)(S2CNPr2)] and [CpRu(PPh3)(S2CNMeBu)]. Inorg. Chim. Acta 2006, 359, 1018–1022. [Google Scholar] [CrossRef]
  59. Lalrempuia, R.; Suante, H.; Yennawar, H.P.; Kollipara, M.R. Reactivity of the [CpM(PPh3)2]+ (M=Ru, Os) fragment with diethyldithiocarbamate. Polyhedron 2007, 26, 867–870. [Google Scholar] [CrossRef]
  60. El-Khateeb, M.; Al-Noaimi, M.; Harb, M.; Gorls, H.; Weigand, W. Half-sandwich ruthenium complexes of heterocyclic-dithiocarboxylato ligands. Jordan J. Chem. 2008, 3, 147. [Google Scholar]
  61. Lu, X.L.; Vittal, J.J.; Tiekink, E.R.T.; Tan, G.K.; Kuan, S.L.; Goh, L.Y.; Hor, T.S.A. Comparative reactivity studies of dppf-containing CpRuII and (C6Me6)RuII complexes towards different donor ligands (dppf=1,1′-bis(diphenylphosphino)ferrocene). J. Organomet. Chem. 2004, 689, 1978–1990. [Google Scholar] [CrossRef]
  62. Rheingold, A.L.; Bitterwolf, T.E. Carbonyl-cyclopentadienyl-(N,N-dimethyldithiocarbamato)-ruthenium. CSD Commun. 2019. [Google Scholar] [CrossRef]
  63. Cheung, W.-M.; Zhang, Q.-F.; Wiliams, I.D.; Leung, W.-H. An unsaturated half-sandwich ruthenium(II) complex containing a dithioimidodiphosphinate ligand. Inorg. Chim. Acta 2006, 359, 782–788. [Google Scholar] [CrossRef]
  64. Tay, E.P.L.; Kuan, S.L.; Leong, W.K.; Goh, L.Y. Synthetic and X-ray structural and reactivity studies of Cp*RuIV complexes containing bidentate dithiocarbonate, xanthate, carbonate, and phosphinate ligands (Cp* = η5-C5Me5). Inorg. Chem. 2007, 46, 1440–1450. [Google Scholar] [CrossRef]
  65. Kuan, S.L.; Tay, E.P.L.; Leong, W.K.; Goh, L.Y.; Lin, C.Y.; Gill, P.M.W.; Webster, R.D. Highly oxidized ruthenium organometallic compounds. The synthesis and one-electron electrochemical oxidation of [Cp*RuIVCl2(S2CR)] (Cp* = η5-C5Me5, R = NMe2, NEt2, OiPr). Organometallics 2006, 25, 6134–6141. [Google Scholar] [CrossRef]
  66. Xu, C.; Pullarkat, S.A.; Goh, L.Y. Bis(allyl)ruthenium(iv)-initiated S–S and C–S bond cleavages in tetraalkylthiuram sulfides. Formation and X-ray crystal structures of dithiocarbamato complexes. Aust. J. Chem. 2009, 62, 1537–1543. [Google Scholar] [CrossRef]
  67. Dou, Y.-H.; Xu, S.-D.; Chen, Y.; Wu, X.-H. Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes. Phosphorus Sulfur Silicon Relat. Elem. 2017, 192, 1219–1223. [Google Scholar] [CrossRef]
  68. Seino, H.; Yoshikawa, T.; Hidai, M.; Mizobe, Y. Preparation of mononuclear and dinuclear Rh hydrotris(pyrazolyl)borato complexes containing arenethiolato ligands and conversion of the mononuclear complexes into dinuclear Rh–Rh and Rh–Ir complexes with bridging arenethiolato ligands. Dalton Trans. 2004, 3593–3600. [Google Scholar] [CrossRef] [PubMed]
  69. Dixon, L.S.H.; Hill, A.F.; Sinha, A.; Ward, J.S. N-heterocyclic silyl pincer ligands. Organometallics 2014, 33, 653–658. [Google Scholar] [CrossRef]
  70. Mansouri, G.; Heidarizadi, F.; Naghipour, A.; Notash, B. Synthesis, characterization and antibacterial study of cyclometalated rhodium(III) complex containing dithiocarbamate. J. Mol. Struct. 2016, 1121, 128–134. [Google Scholar] [CrossRef]
  71. Mukherjee, T.; Sen, B.; Patra, A.; Banerjee, S.; Hundal, G.; Chattopadhyay, P. Cyclometalated rhodium(III) complexes bearing dithiocarbamate derivative: Synthesis, characterization, interaction with DNA and biological study. Polyhedron 2014, 69, 127–134. [Google Scholar] [CrossRef]
  72. Steffen, A.; Tay, M.G.; Batsanov, A.S.; Howard, J.A.K.; Beeby, A.; Vuong, K.Q.; Sun, X.-Z.; George, M.W.; Marder, T.B. 2,5-Bis(p-R-arylethynyl)rhodacyclopentadienes show intense fluorescence: Denying the presence of a heavy atom. Angew. Chem. Int. Ed. 2010, 49, 2349–2353. [Google Scholar] [CrossRef] [PubMed]
  73. Bobinihi, F.F.; Onwudiwe, D.C.; Ekennia, A.C.; Okpareke, O.C.; Arderne, C.; Lane, J.R. Group 10 metal complexes of dithiocarbamates derived from primary anilines: Synthesis, characterization, computational and antimicrobial studies. Polyhedron 2019, 158, 296–310. [Google Scholar] [CrossRef]
  74. Poirier, S.; Tailleur, E.; Lynn, H.; Reber, C. Characterization of Pd⋯H–C interactions in bis-dimethyldithiocarbamate palladium(II) and its deuterated analog by luminescence spectroscopy at variable pressure. Dalton Trans. 2016, 45, 10883–10886. [Google Scholar] [CrossRef]
  75. Poirier, S.; Lynn, H.; Reber, C.; Tailleur, E.; Marchivie, M.; Guionneau, P.; Probert, M.R. Variation of M···H–C interactions in square-planar complexes of nickel(II), palladium(II), and platinum(II) probed by luminescence spectroscopy and X-ray diffraction at variable pressure. Inorg. Chem. 2018, 57, 7713–7723. [Google Scholar] [CrossRef] [Green Version]
  76. Poirier, S.; Guionneau, P.; Luneau, D.; Reber, C. Why do the luminescence maxima of isostructural palladium(II) and platinum(II) complexes shift in opposite directions? Can. J. Chem. 2014, 92, 958–965. [Google Scholar] [CrossRef] [Green Version]
  77. Birri, A.; Harvey, B.; Hogarth, G.; Subasi, E.; Ugur, F. Allyl palladium dithiocarbamates and related dithiolate complexes as precursors to palladium sulfides. J. Organomet. Chem. 2007, 692, 2448–2455. [Google Scholar] [CrossRef]
  78. Shaheen, F.; Badshah, A.; Gielen, M.; Dusek, M.; Fejfarova, K.; de Vos, D.; Mirza, B. Synthesis, characterization, antibacterial and cytotoxic activity of new palladium(II) complexes with dithiocarbamate ligands: X-ray structure of bis(dibenzyl-1-S:S′-dithiocarbamato)Pd(II). J. Organomet. Chem. 2007, 692, 3019–3026. [Google Scholar] [CrossRef]
  79. Ehsan, M.A.; Ming, H.N.; McKee, V.; Peiris, T.A.N.; Wijayantha-Kahagala-Gamage, U.; Arifin, Z.; Mazhar, M. Vysotskite structured photoactive palladium sulphide thin films from dithiocarbamate derivatives. New J. Chem. 2014, 38, 4083–4091. [Google Scholar] [CrossRef] [Green Version]
  80. Ferreira, I.P.; de Lima, G.M.; Paniago, E.B.; Takahashi, J.A.; Pinheiro, C.B. Synthesis, characterization and antifungal activity of new dithiocarbamate-based complexes of Ni(II), Pd(II) and Pt(II). Inorg. Chim. Acta 2014, 423, 443–449. [Google Scholar] [CrossRef]
  81. Phadnis, P.P.; Jain, V.K.; Schurr, T.; Klein, A.; Lissner, F.; Schleid, T.; Kaim, W. Synthesis, spectroscopy, structure and photophysical properties of dinaphthylmethylarsine complexes of palladium(II) and platinum(II). Inorg. Chim. Acta 2005, 358, 2609–2617. [Google Scholar] [CrossRef]
  82. Bobinihi, F.F.; Onwudiwe, D.C.; Hosten, E.C. Synthesis and characterization of homoleptic group 10 dithiocarbamate complexes and heteroleptic Ni(II) complexes, and the use of the homoleptic Ni(II) for the preparation of nickel sulphide nanoparticles. J. Mol. Struct. 2018, 1164, 475–485. [Google Scholar] [CrossRef]
  83. Hogarth, G.; Rainford-Brent, E.-J.C.-R.C.R.; Kabir, S.E.; Richards, I.; Wilton-Ely, J.D.E.T.; Zhang, Q. Functionalised dithiocarbamate complexes: Synthesis and molecular structures of 2-diethylaminoethyl and 3-dimethylaminopropyl dithiocarbamate complexes [M{S2CN(CH2CH2NEt2)2}n] and [M{S2CN(CH2CH2CH2NMe2)2}n] (n=2, M=Ni, Cu, Zn, Pd; n=3, M=Co). Inorg. Chim. Acta 2009, 362, 2020–2026. [Google Scholar] [CrossRef]
  84. Onwudiwe, D.C.; Ekennia, A.C.; Mogwase, B.M.S.; Olubiyi, O.O.; Hosten, E. Palladium(II) and platinum(II) complexes of N-butyl-N-phenyldithiocarbamate: Synthesis, characterization, biological activities and molecular docking studies. Inorg. Chim. Acta 2016, 450, 69–80. [Google Scholar] [CrossRef]
  85. Konarev, D.V.; Kovalevsky, A.Y.; Otsuka, A.; Saito, G.; Lyubovskaya, R.N. Neutral and ionic complexes of C60 with metal dibenzyldithiocarbamates. Reversible dimerization of C60•− in ionic multicomponent complex [CrI(C6H6)2•+]·(C60•−)·0.5[Pd(dbdtc)2]. Inorg. Chem. 2005, 44, 9547–9553. [Google Scholar] [CrossRef]
  86. Gupta, A.N.; Kumar, V.; Singh, V.; Manar, K.K.; Drew, M.G.B.; Singh, N. Intermolecular anagostic interactions in group 10 metal dithiocarbamates. CrystEngComm 2014, 16, 9299–9307. [Google Scholar] [CrossRef]
  87. Yadav, M.K.; Rajput, G.; Prasad, L.B.; Drew, M.G.B.; Singh, N. Rare intermolecular M···H–C anagostic interactions in homoleptic Ni(II)–Pd(II) dithiocarbamate complexes. New J. Chem. 2015, 39, 5493–5499. [Google Scholar] [CrossRef]
  88. Genre, C.; Levasseur-Theriault, G.; Reber, C. Emitting-state properties of square-planar dithiocarbamate complexes of palladium(II) and platinum(II) probed by pressure-dependent luminescence spectroscopy. Can. J. Chem. 2009, 87, 1625–1635. [Google Scholar] [CrossRef]
  89. Shaheen, F.; Badshah, A.; Anjum, S.; Saqib, A. Bis(piperidine-1-dithiocarbamato-κ2S,S′)palladium(II). Acta Crystallogr. Sect. E Struct. Rep. Online 2006, 62, m329–m330. [Google Scholar] [CrossRef]
  90. Shahzadi, S.; Ali, S.; Badshah, A.; Shaheen, F.; Ahmed, F.; Fettouhi, M. Synthesis and crystal structure of bis(4-methylpiperidine-dithiocarbamato-S,S′)-palladium(II). J. Chem. Cryst. 2006, 36, 567–570. [Google Scholar] [CrossRef]
  91. Mukherjee, T.; Sarkar, S.; Marek, J.; Zangrando, E.; Chattopadhyay, P. Palladium(II) complexes of dithiocarbamic acids: Synthesis, characterization, crystal structure and DNA binding study. Transit. Met. Chem. 2012, 37, 155–161. [Google Scholar] [CrossRef]
  92. Torres-Huerta, A.; Höpfl, H.; Tlahuext, H.; Hernández-Ahuactzi, I.F.; Sánchez, M.; Reyes-Martínez, R.; Morales-Morales, D. Dinuclear macrocyclic palladium dithiocarbamates derived from the homologous series of aliphatic 1,x-diamines (x = 4–10). Eur. J. Inorg. Chem. 2013, 2013, 61–69. [Google Scholar] [CrossRef]
  93. Webber, P.R.A.; Drew, M.G.B.; Hibbert, R.; Beer, P.D. Transition metal-directed self-assembly of calix[4]arene based dithiocarbamate ligands. Dalton Trans. 2004, 1127–1135. [Google Scholar] [CrossRef]
  94. Sherwood, R.; de Rivera, F.G.; Wan, J.H.; Zhang, Q.; White, A.J.P.; Rossell, O.; Hogarth, G.; Wilton-Ely, J.D.E.T. Multimetallic complexes based on a diphosphine-dithiocarbamate “janus” ligand. Inorg. Chem. 2015, 54, 4222–4230. [Google Scholar] [CrossRef] [Green Version]
  95. Gupta, R.K.; Pandey, R.; Singh, R.; Srivastava, N.; Maiti, B.; Saha, S.; Li, P.; Xu, Q.; Pandey, D.S. Heteroleptic dipyrrinato complexes containing 5-ferrocenyldipyrromethene and dithiocarbamates as coligands: Selective chromogenic and redox probes. Inorg. Chem. 2012, 51, 8916–8930. [Google Scholar] [CrossRef]
  96. Singh, S.K.; Kumar, V.; Drew, M.G.B.; Singh, N. Syntheses, crystal structures and photoluminescent properties of new heteroleptic Ni(II) and Pd(II) complexes of ferrocene functionalized dithiocarbamate-and dipyrromethene ligands. Inorg. Chem. Commun. 2013, 37, 151–154. [Google Scholar] [CrossRef]
  97. Li, H.; Jiang, X.-F.; Yu, S.-Y. Syntheses, characterization and crystal structures of dithiocarbamate-based mononuclear palladium(II) complexes. Chin. J. Struct. Chem. 2017, 36, 1185–1192. [Google Scholar] [CrossRef]
  98. Wiench, J.W.; Michon, C.; Ellern, A.; Hazendonk, P.; Iuga, A.; Angelici, R.J.; Pruski, M. Solid-state NMR investigations of the immobilization of a BF4− salt of a palladium(II) complex on silica. J. Am. Chem. Soc. 2009, 131, 11801–11810. [Google Scholar] [CrossRef] [PubMed]
  99. Xu, S.D.; Wu, X.H. Bimetallic DppfM(II) (M = Pt and Pd) dithiocarbamate complexes: Synthesis, characterization, and anticancer activity. J. Chem. Res. 2019, 43, 437–442. [Google Scholar] [CrossRef]
  100. Jantan, K.A.; Kwok, C.Y.; Chan, K.W.; Marchiò, L.; White, A.J.P.; Deplano, P.; Serpe, A.; Wilton-Ely, J.D.E.T. From recovered metal waste to high-performance palladium catalysts. Green Chem. 2017, 19, 5846–5853. [Google Scholar] [CrossRef] [Green Version]
  101. Knight, E.R.; Leung, N.H.; Lin, Y.H.; Cowley, A.R.; Watkin, D.J.; Thompson, A.L.; Hogarth, G.; Wilton-Ely, J.D.E.T. Multimetallic arrays: Symmetrical bi-, tri- and tetrametallic complexes based on the group 10 metals and the functionalisation of gold nanoparticles with nickel-phosphine surface units. Dalton Trans. 2009, 3688–3697. [Google Scholar] [CrossRef]
  102. Oliver, K.; White, A.J.P.; Hogarth, G.; Wilton-Ely, J.D.E.T. Multimetallic complexes of group 10 and 11 metals based on polydentate dithiocarbamate ligands. Dalton Trans. 2011, 40, 5852–5864. [Google Scholar] [CrossRef]
  103. Khan, H.; Badshah, A.; Zia-ur-Rehman; Said, M.; Murtaza, G.; Shah, A.; Butler, I.S.; Ahmed, S.; Fontaine, F.-G. New dimeric and supramolecular mixed ligand palladium(II) dithiocarbamates as potent DNA binders. Polyhedron 2012, 39, 1–8. [Google Scholar] [CrossRef]
  104. Prakasam, B.A.; Lahtinen, M.; Peuronen, A.; Muruganandham, M.; Kolehmainen, E.; Haapaniemi, E.; Sillanpaa, M. Synthesis, NMR spectral and structural studies on mixed ligand complexes of Pd(II) dithiocarbamates: First structural report on palladium(II) dithiocarbamate with SCN− ligand. J. Mol. Struct. 2016, 1108, 195–202. [Google Scholar] [CrossRef]
  105. Shaheen, F.; Badshah, A.; Gielen, M.; Gieck, C.; de Vos, D. Synthesis, characterization and in vitro cytotoxicity of palladium(II) complexes with mixed ligands. X-ray diffraction study of C31H36ClNPPdS2. Appl. Organomet. Chem. 2007, 21, 633–640. [Google Scholar] [CrossRef]
  106. Shaheen, F.; Najam-Ul-Haq, M.; Wurst, K.; Badshah, A.; Ali, S. Chloro(4-methylpiperidine-1-dithiocarbamato-κ2S:S′)(triphenylphosphine-κP)palladium(II). Acta Crystallogr. Sect. E Struct. Rep. Online 2006, 62, m136–m137. [Google Scholar] [CrossRef] [Green Version]
  107. Shaheen, F.; Badshah, A.; Gielen, M.; Croce, G.; Florke, U.; de Vos, D.; Ali, S. In vitro assessment of cytotoxicity, anti-inflammatory, antifungal properties and crystal structures of metallacyclic palladium(II) complexes. J. Organomet. Chem. 2010, 695, 315–322. [Google Scholar] [CrossRef]
  108. Florke, U. Chloro-(3,4-dihydroisoquinoline-2(1H)-carbodithioato)-(tris(2-methylphenyl)phosphine)-palladium(ii). CSD Commun. 2016. [Google Scholar] [CrossRef]
  109. Nawaz, H.; Waseem, A.; Nafees, M.; Arshad, M.N.; Rashid, U. Synthesis, characterization, cytotoxicity and computational studies of new phosphine and carbodithioate based palladium(II) complexes. Appl. Organomet. Chem. 2017, 31, e3771. [Google Scholar] [CrossRef]
  110. Khan, S.Z.; Butler, I.S.; Belanger-Gariepy, F. New ternary palladium(II) complexes: Synthesis, characterization, in vitro anticancer and antioxidant activities. Inorg. Chem. Commun. 2019, 105, 140–146. [Google Scholar] [CrossRef]
  111. Khan, S.Z.; Amir, M.K.; Ullah, I.; Aamir, A.; Pezzuto, J.M.; Kondratyuk, T.; Bélanger-Gariepy, F.; Ali, A.; Khan, S.; Zia-ur-Rehman. New heteroleptic palladium(II) dithiocarbamates: Synthesis, characterization, packing and anticancer activity against five different cancer cell lines. Appl. Organomet. Chem. 2016, 30, 392–398. [Google Scholar] [CrossRef]
  112. Khan, S.Z.; Amir, M.K.; Abbasi, R.; Tahir, M.N.; Zia-ur-Rehman. New 3D and 2D supramolecular heteroleptic palladium(II) dithiocarbamates as potent anticancer agents. J. Coord. Chem. 2016, 69, 2999–3009. [Google Scholar] [CrossRef]
  113. Khan, S.Z.; Amir, M.K.; Naseer, M.M.; Abbasi, R.; Mazhar, K.; Tahir, M.N.; Awan, I.Z.; Zia-ur-Rehman. Heteroleptic Pd(II) dithiocarbamates: Synthesis, characterization, packing and in vitro anticancer activity against HeLa cell line. J. Coord. Chem. 2015, 68, 2539–2551. [Google Scholar] [CrossRef]
  114. Khan, S.Z.; Amir, M.K.; Ullah, I.; Akhter, M.S.; Bélanger-Gariepy, F. Heteroleptic palladium(II) dithiocarbamates: Synthesis, characterization and in vitro biological screening. J. Mol. Struct. 2018, 1156, 564–570. [Google Scholar] [CrossRef]
  115. Khan, H.; Badshah, A.; Said, M.; Murtaza, G.; Ahmad, J.; Jean-Claude, B.J.; Todorova, M.; Butler, I.S. Anticancer metallopharmaceutical agents based on mixed-ligand palladium(II) complexes with dithiocarbamates and tertiary organophosphine ligands. Appl. Organomet. Chem. 2013, 27, 387–395. [Google Scholar] [CrossRef]
  116. Khan, H.; Badshah, A.; Murtaz, G.; Said, M.; Neuhausen, C.; Todorova, M.; Jean-Claude, B.J.; Butler, I.S. Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes. Eur. J. Med. Chem. 2011, 46, 4071–4077. [Google Scholar] [CrossRef]
  117. Khan, H.; Badshah, A.; Said, M.; Murtaza, G.; Sirajuddin, M.; Ahmad, J.; Butler, I.S. Synthesis, structural characterization and biological screening of heteroleptic palladium(II) complexes. Inorg. Chim. Acta 2016, 447, 176–182. [Google Scholar] [CrossRef]
  118. Chan, E.Y.Y.; Zhang, Q.-F.; Sau, Y.-K.; Lo, S.M.F.; Sung, H.H.Y.; Williams, I.D.; Haynes, R.K.; Leung, W.-H. Chiral bisphosphinite metalloligands derived from a P-chiral secondary phosphine oxide. Inorg. Chem. 2004, 43, 4921–4926. [Google Scholar] [CrossRef]
  119. Serrano, J.L.; García, L.; Pérez, J.; Pérez, E.; Galiana, J.M.; García, J.; Martínez, M.; Sánchez, G.; da Silva, I. New cyclometallated precursors of unsubstituted N-phenylpyrazole [{Pd(phpz)(μ-X)}2] (X = AcO or OH) and study of their reactivity towards selected ligands. Dalton Trans. 2011, 40, 156–168. [Google Scholar] [CrossRef]
  120. Kondrashov, M.; Fleckhaus, A.; Gritcenko, R.; Wendt, O.F. Crystal structure of (piperidine-1-carbodithioato-κ2S,S)[2-(pyridin-2-yl)phenyl-κ2C1,N]palladium(II). Acta Crystallogr. Sect. E Crystallogr. Commun. 2015, 71, m166. [Google Scholar] [CrossRef] [PubMed]
  121. Lentijo, S.; Miguel, J.A.; Espinet, P. Cyclopalladated complexes of perylene imine: Mononuclear complexes with five- or six-membered metallacycles. Dalton Trans. 2011, 40, 7602–7609. [Google Scholar] [CrossRef] [PubMed]
  122. Cheung, K.-M.; Zhang, Q.-F.; Mak, W.-L.; Sung, H.H.Y.; Williams, I.D.; Leung, W.-H. Bimetallic complexes with porphyrins containing a cyclometalated phenylpyridine group. J. Organomet. Chem. 2005, 690, 253–260. [Google Scholar] [CrossRef]
  123. Schildbach, D.; Arroyo, M.; Lehmen, K.; Martin-Barrios, S.; Sierra, L.; Villafane, F.; Strohmann, C. [(Piperidinomethyl)silylmethyl] cyclopalladated complexes:  Their synthesis, reactivity, and solid state structures. Organometallics 2004, 23, 3228–3238. [Google Scholar] [CrossRef]
  124. Wang, H.-F.; Yih, K.-H.; Leeb, G.-H.; Huang, S.-L. Synthesis, reactivity and crystal structures of the Palladium(II) complexes with the pyrimidine containing ligand: Crystal structures of [Pd(PPh3)(η1-C4H3N2)(η2-S2CNC4H8)] and [Pd(PPh3)(η1-C4H3N2)(η2-Tp)]. J. Chin. Chem. Soc. 2011, 58, 174–180. [Google Scholar] [CrossRef]
  125. Kwok, W.-H.; Lu, G.-L.; Rickard, C.E.F.; Roper, W.R.; Wright, L.J. The structurally characterised silyl complexes, Os(κ2-S2CNMe2)-(SiMeCl2)(CO)(PPh3)2 and Os(κ2-S2CNMe2)(SiCl3)(CO)(PPh3)2, which have remarkably unreactive Si–Cl bonds. J. Organomet. Chem. 2006, 691, 2593–2598. [Google Scholar] [CrossRef]
  126. Albrecht, M.; Kwok, W.-H.; Lu, G.-L.; Rickard, C.E.F.; Roper, W.R.; Salter, D.M.; Wright, L.J. Osmadisiloxane and osmastannasiloxane complexes derived from silanolate complexes of osmium(II). Inorg. Chim. Acta 2005, 358, 1407–1419. [Google Scholar] [CrossRef]
  127. Möhlen, M.M.; Rickard, C.E.F.; Roper, W.R.; Whittell, G.R.; Wright, L.J. Syntheses, reactions, and structures of osmium(II) stannyl complexes with the simple stannyl ligands −SnH3, −SnH2Me, and −SnHMe2. Inorg. Chim. Acta 2007, 360, 1287–1297. [Google Scholar] [CrossRef]
  128. Lu, G.L.; Möhlen, M.M.; Rickard, C.E.; Roper, W.R.; Wright, L.J. A cyclic osmastannyl complex, Os(κ2(Sn,P)-SnMe2C6H4PPh2)(κ2-S2CNMe2)(CO)(PPh3) derived from the osmastannol complex, Os(SnMe2OH)(κ2-S2CNMe2)(CO)(PPh3)2. Inorg. Chim. Acta 2005, 358, 4145–4155. [Google Scholar] [CrossRef]
  129. Möhlen, M.M.; Rickard, C.E.F.; Roper, W.R.; Whittell, G.R.; Wright, L.J. Syntheses, reactions, and structures of osmium(II) distannyl complexes, LnOs–SnMe2SnR3 (R = Me, Ph), from reaction between LnOs–SnClMe2 and either LiSnMe3 or KSnPh3. J. Organomet. Chem. 2006, 691, 4065–4075. [Google Scholar] [CrossRef]
  130. Karim, M.M.; Abser, M.N.; Hassan, M.R.; Ghosh, N.; Alt, H.G.; Richards, I.; Hogarth, G. Oxidative-addition of thiuram disulfides to osmium(0): Synthesis of cis-[Os(CO)2(S2CNR2)2] (R = Me, Et, Cy, CH2CH2OMe) and molecular structures of cis-[Os(CO)2(S2CNMe2)2] and [(MeOCH2CH2)2NCS]2. Polyhedron 2012, 42, 84–88. [Google Scholar] [CrossRef]
  131. Bhoumik, N.C.; Saha, T.K.; Ghosh, S.; Nesterov, V.N.; Richmond, M.G.; Kabir, S.E. Facile Os-Os bond cleavage in the reactions of [Os3(CO)10(NCMe)2] and [Os3(CO)10(μ-H)2] with tetramethylthiuram disulfide (tmtd): Syntheses and crystal structures of new polynuclear osmium carbonyl complexes containing a dimethyldithiocarbamate ligand(s). J. Organomet. Chem. 2020, 911, 121133. [Google Scholar] [CrossRef]
  132. Garcia-Orozco, I.; Pastor, C.J.; Souto, B.; Delgado, E.; Hernandez, E.; Alvarez-Toledano, C. Nonacarbonyl-μ3-N,N-diethyldithiocarbamato-κ3S:S:S′-μ-hydrido-triosmium(3 Os-Os). Acta Crystallogr. Sect. E Crystallogr. Commun. 2005, 61, m1644–m1645. [Google Scholar] [CrossRef] [Green Version]
  133. Chen, L.-Q. (N,N′-Diethyldithiocarbamato-κ2S,S′)bis[2-(2-pyridyl)phenyl-κ 2C1,N]iridium(III). Acta Crystallogr. Sect. E Crystallogr. Commun. 2007, 63, m2078. [Google Scholar] [CrossRef]
  134. Lau, M.-K.; Cheung, K.-M.; Zhang, Q.-F.; Song, Y.; Wong, W.-T.; Williams, I.D.; Leung, W.-H. Iridium(III) and rhodium(III) cyclometalated complexes containing sulfur and selenium donor ligands. J. Organomet. Chem. 2004, 689, 2401–2410. [Google Scholar] [CrossRef]
  135. Wang, X.-M.; Qiang, J.-Y.; Jia, A.-Q.; Tong, B.; Zhang, Q.-F. Syntheses, crystal structures and phosphorescence properties of cyclometalated iridium(III) bis(pyridylbenzaldehyde) complexes with dithiolate ligands. Z. Naturforsch. B Chem. Sci. 2017, 72, 941–946. [Google Scholar] [CrossRef]
  136. Lu, G.-Z.; Tu, Z.-L.; Liu, L.; Zhang, W.-W.; Zheng, Y.-X. Fast synthesis of iridium (iii) complexes with sulfur-containing ancillary ligand for high-performance green OLEDs with EQE exceeding 31%. J. Mater. Chem. C 2019, 7, 7273–7278. [Google Scholar] [CrossRef]
  137. Lu, G.-Z.; Wu, R.; Liu, L.; Zhou, L.; Zheng, Y.-X.; Zhang, W.-W.; Zuo, J.-L.; Zhang, H. A series of red iridium(III) complexes using flexible dithiocarbamate derivatives as ancillary ligands for highly efficient phosphorescent OLEDs. Mater. Chem. Front. 2019, 3, 860–866. [Google Scholar] [CrossRef]
  138. Lu, G.Z.; Su, N.; Yang, H.Q.; Zhu, Q.; Zhang, W.-W.; Zheng, Y.-X.; Zhou, L.; Zuo, J.-L.; Chen, Z.-X.; Zhang, H.-J. Rapid room temperature synthesis of red iridium(iii) complexes containing a four-membered Ir–S–C–S chelating ring for highly efficient OLEDs with EQE over 30%. Chem. Sci. 2019, 10, 3535–3542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  139. Su, N.; Li, F.-L.; Zheng, Y.-X. Four-membered red iridium(III) complexes with Ir–S–C–S structures for efficient organic light-emitting diodes. J. Mater. Chem. C 2020, 8, 7411–7416. [Google Scholar] [CrossRef]
  140. Lu, G.-Z.; Li, X.; Liu, L.; Zhou, L.; Zheng, Y.-X.; Zhang, W.-W.; Zuo, J.-L.; Zhang, H. Efficient phosphorescent red iridium(III) complexes containing a four-membered Ir–S–C–S ring backbone and large hindered spacers for high-performance OLEDs. J. Mater. Chem. C 2019, 7, 3862–3868. [Google Scholar] [CrossRef]
  141. Mei, Q.; Chen, C.; Tian, R.; Yang, M.; Tong, B.; Hua, Q.; Shi, Y.; Fan, Q.; Ye, S. Highly efficient orange phosphorescent organic light-emitting diodes based on an iridium(III) complex with diethyldithiocarbamate (S^S) as the ancillary ligand. RSC Adv. 2016, 6, 64003–64008. [Google Scholar] [CrossRef]
  142. Tong, B.; Ma, P.; Zhang, M.; Liu, Y.; Mei, Q.; Zhang, Q.-F. Phosphorescent iridium(III) carbodithioate complex for the detection of Hg2+ and acetonitrile. Inorg. Chem. Commun. 2013, 37, 121–126. [Google Scholar] [CrossRef]
  143. Katlenok, E.A.; Zolotarev, A.A.; Ivanov, A.Y.; Smirnov, S.N.; Baichurin, R.I.; Balashev, K.P. Complexes of Ir(III) and Pt(II) with cyclometallated 2-phenylbenzothiazole and chelating diethyldithiocarbamate and o-ethyldithiocarbonate ions: Structures and optical and electrochemical properties. Russ. J. Coord. 2016, 42, 178–186. [Google Scholar] [CrossRef]
  144. Katlenok, E.A.; Zolotarev, A.A.; Balashev, K.P. Influence of ligand donor-acceptor properties on the structure, optical, and electrochemical characteristics of Ir(III) complexes with cyclometallated 2-phenylbenzotiazole. Russ. J. Gen. Chem. 2016, 86, 2508–2514. [Google Scholar] [CrossRef]
  145. Chen, L.; Wu, Z.; Yang, J.; Zhang, S. The synthesis and crystal structure of bis(2-(benzo[d]thiazol-2-yl)-5-methylbenzen-1-ido-κ2C,N)-(N,N′-diethyldithiocarbamato-κ2S,S′)iridium(III), C33H30N3S4Ir. Z. Kristallogr. New Cryst. Struct. 2019, 234, 1173–1176. [Google Scholar] [CrossRef]
  146. Chen, L.; Yang, C.; Qin, J.; Gao, J.; You, H.; Ma, D. Synthesis, structure, electrochemistry, photophysics and electroluminescence of 1,3,4-oxadiazole-based ortho-metalated iridium(III) complexes. J. Organomet. Chem. 2006, 691, 3519–3530. [Google Scholar] [CrossRef]
  147. Chen, L.; Yang, C.; Li, M.; Qin, J.; Gao, J.; You, H.; Ma, D. Supramolecular architectures, photophysics, and electroluminescence of 1,3,4-oxadiazole-based iridium(III) complexes: From μ-dichloro bridged dimer to mononuclear complexes. Cryst. Growth Des. 2007, 7, 39–46. [Google Scholar] [CrossRef]
  148. Clark, G.R.; Ferguson, L.A.; McIntosh, A.E.; Söhnel, T.; Wright, L.J. Functionalization of metallabenzenes through nucleophilic aromatic substitution of hydrogen. J. Am. Chem. Soc. 2010, 132, 13443–13452. [Google Scholar] [CrossRef]
  149. Scharwitz, M.; van Almsick, T.; Sheldrick, W.S. Carbonyl(diethyldithioarbamato)(η5-pentamethylcyclopentadienyl)iridium(III) trifluoromethanesulfonate. Acta Crystallogr. Sect. E Crystallogr. Commun. 2007, E63, m105–m107. [Google Scholar] [CrossRef]
  150. Scharwitz, M.; Oppel, I.M.; Sheldrick, W.S. Bis(μ-diethyldithiocarbamato)bis[(η5-pentamethylcyclopentadienyl)iridium(III)] bis(perchlorate). Acta Crystallogr. Sect. E Crystallogr. Commun. 2007, 63, m2065–m2066. [Google Scholar] [CrossRef]
  151. Kotera, M.; Sekioka, Y.; Suzuki, T. Structural versatility of 5-methyltetrazolato complexes of (η5-pentamethylcyclopentadienyl)iridium(III) incorporating 2,2′-bipyridine, N,N-dimethyldithiocarbamate, or 2-pyridinethiolate ligands. Inorg. Chem. 2008, 47, 3498–3508. [Google Scholar] [CrossRef] [PubMed]
  152. Shaver, A.; Mouatassim, B.E.; Mortini, F.; Belanger-Gariepy, F.; Lough, A. Reactions of (η5-C5Me5)Ir(PMe3)(SH)2 and (η5-C5Me5)Ir(PMe3)(SH)(H) with thionylaniline (PhNSO) to give novel iridium S3O and S2O complexes. Organometallics 2007, 26, 4229–4233. [Google Scholar] [CrossRef]
  153. Ariyoshi, K.; Suzuki, T.; Mayer, J.M.; Kojima, M. Reactivities of the N-atom-inserted ligands, NSC(NR2)S2− and SN=C(NR2)S2−, in iridium(III) complexes. Chem. Lett. 2011, 40, 831–833. [Google Scholar] [CrossRef]
  154. Onwudiwe, D.C.; Mugo, J.N.; Hrubaru, M.; Hosten, E. Bis diallyl dithiocarbamate Pt(II) complex: Synthesis, characterization, thermal decomposition studies, and experimental and theoretical studies on its crystal structure. J. Sulfur Chem. 2015, 36, 36–47. [Google Scholar] [CrossRef]
  155. Zaeva, A.S.; Ivanov, M.A.; Gerasimenko, A.V.; Ivanov, A.V.; Antzutkin, O.N. Dialkyldithiocarbamate platinum(II) complexes of [Pt(S2CNR2)2] (R = iso-C3H7, iso-C4H9): Preparation, 13C CP-MAS NMR, molecular structure, supramolecular self-assembly and thermal behaviour. Polyhedron 2020, 175, 114166. [Google Scholar] [CrossRef]
  156. Meletov, K.P.; Konarev, D.V. Raman study of the pressure-induced phase transitions in the molecular donor–acceptor complex {Pt(dbdtc)2}C60. Chem. Phys. Lett. 2012, 553, 21–25. [Google Scholar] [CrossRef]
  157. Ehsan, M.A.; Younas, M.; Rehman, A.; Altaf, M.; Khan, M.Y.; Al-Ahmed, A.; Ahmad, S.; Isab, A.A. Synthesis and utilization of platinum(II) dialkyldithiocarbamate precursors in aerosol assisted chemical vapor deposition of platinum thin films as counter electrodes for dye-sensitized solar cells. Polyhedron 2019, 166, 186–195. [Google Scholar] [CrossRef]
  158. Poirier, S.; Rahmani, F.; Reber, C. Large d–d luminescence energy variations in square-planar bis(dithiocarbamate) platinum(II) and palladium(II) complexes with near-identical MS4 motifs: A variable-pressure study. Dalton Trans. 2017, 46, 5279–5287. [Google Scholar] [CrossRef]
  159. Poirier, S.; Roberts, R.J.; Le, D.; Leznoff, D.B.; Reber, C. Interpreting effects of structure variations induced by temperature and pressure on luminescence spectra of platinum(II) bis(dithiocarbamate) compounds. Inorg. Chem. 2015, 54, 3728–3735. [Google Scholar] [CrossRef] [PubMed]
  160. Leka, Z.; Vojta, D.; Kosovic, M.; Latinovic, N.; Dakovic, M.; Visnjevac, A. Syntheses, structures and antifungal activities of novel Co, Mo and Pt complexes with triammonium N,N-diacetatedithiocarbamate. Polyhedron 2014, 80, 233–242. [Google Scholar] [CrossRef]
  161. Liebing, P.; Witzorke, J.; Oehler, F.; Schmeide, M. Dithiocarbamatocarboxylate (DTCC) ligands-building blocks for hard/soft-heterobimetallic coordination polymers. Inorg. Chem. 2020, 59, 2825–2832. [Google Scholar] [CrossRef]
  162. Ajibade, P.A.; Fatokun, A.A.; Andrew, F.P. Synthesis, characterization and anti-cancer studies of Mn(II), Cu(II), Zn(II) and Pt(II) dithiocarbamate complexes-crystal structures of the Cu(II) and Pt (II) complexes. Inorg. Chim. Acta 2020, 504, 119431. [Google Scholar] [CrossRef]
  163. Andrew, F.P.; Ajibade, P.A. Synthesis, characterization and anticancer studies of bis(1-phenylpiperazine dithiocarbamato) Cu(II), Zn(II) and Pt(II) complexes: Crystal structures of 1-phenylpiperazine dithiocarbamato-S,S′ zinc(II) and Pt(II). J. Mol. Struct. 2018, 1170, 24–29. [Google Scholar] [CrossRef]
  164. Ivanov, M.A.; Zaeva, A.S.; Gerasimenko, A.V.; Ivanov, A.V. Platinum(II) cyclo-hexamethylenedithiocarbamate complex, [Pt{S2CN(CH2)6}2] and its solvated form, [Pt{S2CN(CH2)6}2]·CHCl3: Crystal and molecular structures, 13C CP/MAS NMR data, and thermal behavior. Russ. J. Coord. Chem. 2013, 39, 764–770. [Google Scholar] [CrossRef]
  165. Keter, F.K.; Guzei, I.A.; Darkwa, J. N-heterocyclic dithiocarbamate platinum(II) complexes: Unexpected transformation of dithiocarbamate to oxodithiocarbonate in phosphinoplatinum complexes in solution. Inorg. Chem. Commun. 2013, 27, 60–63. [Google Scholar] [CrossRef]
  166. Montagner, D.; Miguel, P.J.S. Unique Pt5 metallacycle: [PtIICl(pyrrolidinedithiocarbamate)]5. Dalton Trans. 2011, 40, 10809–10811. [Google Scholar] [CrossRef] [Green Version]
  167. Isab, A.A.; Ali, M.A.J.; Sharif, S.; Khan, I.U.; Kang, S.K.; Khalid, T.; Saleem, M.; Ahmad, S. Synthesis, crystal structure and antimicrobial studies of chlorido(dimethylsulfoxide-κS)(pyrrolidinedithiocarbamato-κ2S,S′) platinum(II). Inorg. Chem. Commun. 2011, 14, 1962–1965. [Google Scholar] [CrossRef]
  168. Rheingold, A.L.; Reger, D.L. Chloro-(diethylcarbamodithioato)-(triethylphosphine)-platinum. CSD Commun. 2019. [Google Scholar] [CrossRef]
  169. Amir, M.K.; Hayat, F.; Khan, S.Z.; Hogarth, G.; Kondratyuk, T.; Pezzuto, J.M.; Tahir, M.N. Monofunctional platinum(II) dithiocarbamate complexes: Synthesis, characterization and anticancer activity. RSC Adv. 2016, 6, 110517–110524. [Google Scholar] [CrossRef]
  170. Imran, M.; Kondratyuk, T.; Belanger-Gariepy, F. New ternary platinum(II) dithiocarbamates: Synthesis, characterization, anticancer, DNA binding and DNA denaturing studies. Inorg. Chem. Commun. 2019, 103, 12–20. [Google Scholar] [CrossRef]
  171. Verron, R.; Achard, T.; Seguin, C.; Fournel, S.; Bellemin-Laponnaz, S. Synthesis and characterization of n-heterocyclic carbene dithiocarbamate platinum complexes with antitumoral activity. Eur. J. Inorg. Chem. 2020, 2020, 2552–2557. [Google Scholar] [CrossRef]
  172. Forniés, J.; Sicilia, V.; Casas, J.M.; Martín, A.; López, J.A.; Larraz, C.; Borja, P.; Ovejero, C. Pt–Ag clusters and their neutral mononuclear Pt(II) starting complexes: Structural and luminescence studies. Dalton Trans. 2011, 40, 2898–2912. [Google Scholar] [CrossRef]
  173. Expósito, J.E.; Álvarez-Paíno, M.; Aullón, G.; Miguel, J.A.; Espinet, P. Higher fluorescence in platinum(IV) orthometallated complexes of perylene imine compared with their platinum(II) or palladium(II) analogues. Dalton Trans. 2015, 44, 16164–16176. [Google Scholar] [CrossRef] [Green Version]
  174. Paziresh, S.; Aghakhanpour, R.B.; Fuertes, S.; Sicilia, V.; Hosseini, F.N.; Nabavizadeh, S.M. A double rollover cycloplatinated(II) skeleton: A versatile platform for tuning emission by chelating and non-chelating ancillary ligand systems. Dalton Trans. 2019, 48, 5713–5724. [Google Scholar] [CrossRef]
  175. Rheingold, A.L.; Garza, D. (Diethylcarbamodithioato)-(isobutyl)-(triethylphosphine)-platinum(II). CSD Commun. 2015. [Google Scholar] [CrossRef]
  176. Burt, L.K.; Hill, A.F. Heterobimetallic μ2-carbido complexes of platinum and tungsten. Dalton Trans. 2020, 49, 8143–8161. [Google Scholar] [CrossRef]
  177. Fortuño, C.; Martín, A.; Mastrorilli, P.; Latronico, M.; Petrelli, V.; Todisco, S. Stable mixed-valence diphenylphosphanido bridged platinum(II)–platinum(IV) complexes. Dalton Trans. 2020, 49, 4935–4955. [Google Scholar] [CrossRef]
  178. Heard, P.J.; Kite, K.; Nielsen, J.S.; Tocher, D.A. Trimethylplatinum(IV) complexes of dithiocarbamato ligands: An experimental NMR study on the barrier to C–N bond rotation. J. Chem. Soc. Dalton Trans. 2000, 1349–1356. [Google Scholar] [CrossRef] [Green Version]
  179. Evans, D.F. The determination of the paramagnetic susceptibility of substances in solution by nuclear magnetic resonance. J. Chem. Soc. 1959, 2003–2005. [Google Scholar] [CrossRef]
  180. Brustolin, L.; Nardon, C.; Pettenuzzo, N.; Zuin Fantoni, N.; Quarta, S.; Chiara, F.; Gambalunga, A.; Trevisan, A.; Marchiò, L.; Pontisso, P.; et al. Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(II) and Ru(III) aliphatic and aromatic dithiocarbamato complexes. Dalton Trans. 2018, 47, 15477–15486. [Google Scholar] [CrossRef] [PubMed]
  181. Robertson, D.R.; Stephenson, T.A. Metal complexes of sulphur ligands. Part 15. Reaction of bis[(η-arene)dichlororuthenium] and bis[dichloro(η-pentamethylcyclopentadienyl)metal] complexes of rhodium and iridium with various dithioacid ligands. J. Chem. Soc. Dalton Trans. 1978, 486–495. [Google Scholar] [CrossRef]
  182. Forth, C.S. Studies on Sulfur-Capped Osmium and Ruthenium Clusters with Focus on Dynamics; University of London: London, UK, 2003. [Google Scholar]
  183. Van Gaal, H.L.M.; Diesveld, J.W.; Pijpers, F.W.; Van der Linden, J.G.M. Carbon-13 NMR spectra of dithiocarbamates. Chemical shifts, carbon-nitrogen stretching vibration frequencies and. pi.-bonding in the NCS2 fragment. Inorg. Chem. 1979, 18, 3251–3260. [Google Scholar] [CrossRef]
  184. Ursini, C.V. Platinum-195 nuclear magnetic resonance of organometallic compounds. Quím. Nova 1997, 20, 72–82. [Google Scholar] [CrossRef] [Green Version]
  185. Trzaska, S. Cisplatin. Chem. Eng. News 2005, 83, 52. [Google Scholar] [CrossRef]
  186. Kamoon, R.A.; Nadhum, S.A.; Mohammed, M.H. Dithiocarbamates derivatives as anticancer agents: A Review. Ann. Trop. Med. Public Health 2020, 23, S19. [Google Scholar] [CrossRef]
  187. Moharana, P.; Ghosh, D.; Paira, R. Drive to organoruthenium and organoiridium complexes from organoplatinum: Next-generation anticancer metallotherapeutics. Inorg. Chem. Commun. 2021, 124, 108364. [Google Scholar] [CrossRef]
  188. Hussain, S.; Bukhari, I.H.; Ali, S.; Shahzadi, S.; Shahid, M.; Munawar, K.S. Synthesis and spectroscopic and thermogravimetric characterization of heterobimetallic complexes with Sn(IV) and Pd(II); DNA binding, alkaline phosphatase inhibition and biological activity studies. J. Coord. Chem. 2015, 68, 662–677. [Google Scholar] [CrossRef]
  189. Hussain, S.; Ali, S.; Shahzadi, S.; Shahid, M.; Tahir, A.A.; Abbas, S.M.; Riaz, M.; Ahmad, I.; Hussain, I. Multinuclear (Sn/Pd) complexes with disodium 2,2′-(dithiocarboxyazanediyl)diacetate hydrate; Synthesis, characterization and biological activities. J. Coord. Chem. 2017, 70, 4070–4092. [Google Scholar] [CrossRef]
  190. Odularu, A.T.; Ajibade, P.A.; Mbese, J.Z.; Oyedeji, O.O. Developments in platinum-group metals as dual antibacterial and anticancer agents. J. Chem. 2019, 2019, 5459461. [Google Scholar] [CrossRef]
  191. Anant, R.; Kapdi, A.R.; Fairlamb, I.J.S. Anti-cancer palladium complexes: A focus on PdX2L2, palladacycles and related complexes. Chem. Soc. Rev. 2014, 43, 4751–4777. [Google Scholar] [CrossRef]
  192. Fanelli, M.; Formica, M.; Fusi, V.; Giorgi, L.; Micheloni, M.; Paoli, P. New trends in platinum and palladium complexes as antineoplastic agents. Coord. Chem. Rev. 2016, 310, 41–79. [Google Scholar] [CrossRef]
  193. Alam, M.N.; Huq, F. Comprehensive review on tumour active palladium compounds and structure–activity relationships. Coord. Chem. Rev. 2016, 316, 36–67. [Google Scholar] [CrossRef]
  194. Amir, M.K.; Zebkhan, S.; Hayat, F.; Hassan, A.; Butler, I.S.; Zia-ur-Rehman. Anticancer activity, DNA-binding and DNA-denaturing aptitude of palladium(II) dithiocarbamates. Inorg. Chim. Acta 2016, 451, 31–40. [Google Scholar] [CrossRef]
  195. Kang, M.S.; Choi, E.K.; Choi, D.H.; Ryu, S.Y.; Lee, H.H.; Kang, H.C.; Koh, J.T.; Kim, O.S.; Hwang, Y.C.; Yoon, S.J.; et al. Antibacterial activity of pyrrolidine dithiocarbamate. FEMS Microbiol. Lett. 2008, 280, 250–254. [Google Scholar] [CrossRef] [Green Version]
  196. Choi, E.K.; Lee, H.H.; Kang, M.S.; Kim, B.G.; Lim, H.S.; Kim, S.M.; Kang, I.C. Potentiation of bacterial killing activity of zinc chloride by pyrrolidine dithiocarbamate. J. Microbiol. 2010, 48, 40–43. [Google Scholar] [CrossRef]
  197. Yeo, C.I.; Tiekink, E.R.T.; Chew, J. Insights into the Antimicrobial Potential of Dithiocarbamate Anions and Metal-Based Species. Inorganics 2021, 9, 48. [Google Scholar] [CrossRef]
  198. Giovagnini, L.; Marzano, C.; Bettio, F.; Fregona, D. Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agents. J. Inorg. Biochem. 2005, 99, 2139–2150. [Google Scholar] [CrossRef] [PubMed]
  199. Malik, M.A.; Afzaal, M.; O’Brien, P. Precursor Chemistry for Main Group Elements in Semiconducting Materials. Chem. Rev. 2010, 110, 4417–4446. [Google Scholar] [CrossRef] [PubMed]
  200. Knapp, C.E.; Carmalt, C.J. Solution based CVD of main group materials. Chem. Soc. Rev. 2016, 45, 1036–1064. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  201. Fredrick, G.; Erling, R. On the sulfides, selenides, and tellurides of palladium. Acta Chem. Scand. 1956, 10, 1620–1634. [Google Scholar] [CrossRef] [Green Version]
Inorganics 09 00060 g001 550
Figure 1. Canonical forms of dithiocarbamate, RR′NCS2−, R/R′ = H, alkyl and aryl.
Figure 1. Canonical forms of dithiocarbamate, RR′NCS2−, R/R′ = H, alkyl and aryl.
Inorganics 09 00060 g001
Inorganics 09 00060 g002 550
Figure 2. Chemical diagrams of dithiocarbamates L57 to L87.
Figure 2. Chemical diagrams of dithiocarbamates L57 to L87.
Inorganics 09 00060 g002
Inorganics 09 00060 g003 550
Figure 3. Molecular structures of ruthenium complexes: (a) Ru(L8)3 (1), (b) [Ru(L8)3] in the crystal of 4, (c) [Ru2(L8)3] in 5, (d) Ru(L8)2((CH3)2SO)2 (6), (e) (dppb)Ru(L79)2 (10), (f) [Ru(bpy)2(L8)]+ in 11, (g) [(dppm)2Ru(L74)Pd(PPh3)2]2+ in 17, (h) [(PPh3)2Ru(L8)Cl2] in 18, and (i) [(PPh3)Ru(tptz)(L24)]+ in 21. In (e,g,i), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity. Color code in this and subsequent crystallographic images: platinum-group element, orange; other heavy element, brown; chloride, cyan; sulfur, yellow; phosphorus, purple; oxygen, red; nitrogen, blue; carbon, grey; hydrogen, green. Non-participating H atoms are omitted.
Figure 3. Molecular structures of ruthenium complexes: (a) Ru(L8)3 (1), (b) [Ru(L8)3] in the crystal of 4, (c) [Ru2(L8)3] in 5, (d) Ru(L8)2((CH3)2SO)2 (6), (e) (dppb)Ru(L79)2 (10), (f) [Ru(bpy)2(L8)]+ in 11, (g) [(dppm)2Ru(L74)Pd(PPh3)2]2+ in 17, (h) [(PPh3)2Ru(L8)Cl2] in 18, and (i) [(PPh3)Ru(tptz)(L24)]+ in 21. In (e,g,i), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity. Color code in this and subsequent crystallographic images: platinum-group element, orange; other heavy element, brown; chloride, cyan; sulfur, yellow; phosphorus, purple; oxygen, red; nitrogen, blue; carbon, grey; hydrogen, green. Non-participating H atoms are omitted.
Inorganics 09 00060 g003
Inorganics 09 00060 g004 550
Figure 4. Molecular structures of ruthenium complexes: (a) (PEt3)Ru(L8)2(CO) (22), (b) (PPh3)Ru{Ge(p-tolyl)2}(L8)2(CO) in the crystal of 23, (c) (PPh3)Ru(κ2(Si,N)-SiPh2NHC5H4N)(L8)(CO) (24), (d) Ru(B(NCH2PPh2)2C6H4)(L24)(CO) (27), (e) (PPh3)2Ru(H)(L8)(CO) (29), (f) (PPh3)2Ru(C(H)=C(H)BMIDA)(L24)(CO) in 33, (g) (PPh3)2Ru(C(C≡C(Ph)=C(H)Ph)(L84)(CO) (38), (h) (PPh3)2Ru(X)(L24)(CO) (43), (i) (PPh3)2Ru(L24)(CO)Cl in 44, (j) (PPh3)Ru(Ge(p-tolyl)3)(L24)(CO)2 (48), and (k) Ru(L22)(CO)3Cl (49). In (b,c,g,h), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity. Additional color code: silicon, dark green; boron, teal.
Figure 4. Molecular structures of ruthenium complexes: (a) (PEt3)Ru(L8)2(CO) (22), (b) (PPh3)Ru{Ge(p-tolyl)2}(L8)2(CO) in the crystal of 23, (c) (PPh3)Ru(κ2(Si,N)-SiPh2NHC5H4N)(L8)(CO) (24), (d) Ru(B(NCH2PPh2)2C6H4)(L24)(CO) (27), (e) (PPh3)2Ru(H)(L8)(CO) (29), (f) (PPh3)2Ru(C(H)=C(H)BMIDA)(L24)(CO) in 33, (g) (PPh3)2Ru(C(C≡C(Ph)=C(H)Ph)(L84)(CO) (38), (h) (PPh3)2Ru(X)(L24)(CO) (43), (i) (PPh3)2Ru(L24)(CO)Cl in 44, (j) (PPh3)Ru(Ge(p-tolyl)3)(L24)(CO)2 (48), and (k) Ru(L22)(CO)3Cl (49). In (b,c,g,h), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity. Additional color code: silicon, dark green; boron, teal.
Inorganics 09 00060 g004
Inorganics 09 00060 g005 550
Figure 5. Molecular structures of ruthenium complexes: (a) CpRu(PPh3)(L11) (50), (b) {[CpRu(L24)]2(dppf)} in the crystal of 54, (c) CpRu(L8)(CO) (55), (d) [Cp*Ru(L8)(L24)]+ in 57, (e) Cp*Ru(L8)Cl2 (58), (f) Cp*Ru(S2C=O)(L8) (60), (g) [Cp*Ru(L8)Cl]22+ in 64, (h) [(PPh3)2Ru(C(NMe2)OC(NMe2)=S)(L8)]+ in 67, and (i) Ru(X1)(L8)Cl (69). In (b), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity.
Figure 5. Molecular structures of ruthenium complexes: (a) CpRu(PPh3)(L11) (50), (b) {[CpRu(L24)]2(dppf)} in the crystal of 54, (c) CpRu(L8)(CO) (55), (d) [Cp*Ru(L8)(L24)]+ in 57, (e) Cp*Ru(L8)Cl2 (58), (f) Cp*Ru(S2C=O)(L8) (60), (g) [Cp*Ru(L8)Cl]22+ in 64, (h) [(PPh3)2Ru(C(NMe2)OC(NMe2)=S)(L8)]+ in 67, and (i) Ru(X1)(L8)Cl (69). In (b), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity.
Inorganics 09 00060 g005
Inorganics 09 00060 g006 550
Figure 6. Supramolecular aggregation between molecules in the crystals of (a) 3, (b) 8, (c) 1, and (d) 58. The C–H⋯π(RuS2C) interactions are represented by dashed purple lines, and the distances and angles associated with the C–H⋯ π(RuS2C) interactions are given on each image.
Figure 6. Supramolecular aggregation between molecules in the crystals of (a) 3, (b) 8, (c) 1, and (d) 58. The C–H⋯π(RuS2C) interactions are represented by dashed purple lines, and the distances and angles associated with the C–H⋯ π(RuS2C) interactions are given on each image.
Inorganics 09 00060 g006
Inorganics 09 00060 g007 550
Figure 7. Molecular structures of rhodium complexes: (a) Tp*Rh(η2-L24)(η1-L24) (73), (b) [Rh(H){κ3-P,Si,P′-SiPh(NCH2PPh2)2C6H4}(L24)] in the crystal of 74, (c) Rh(phpy)2(L24) (75), and (d) (PMe3)2Rh(X2)(L24) (77). In (b), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity.
Figure 7. Molecular structures of rhodium complexes: (a) Tp*Rh(η2-L24)(η1-L24) (73), (b) [Rh(H){κ3-P,Si,P′-SiPh(NCH2PPh2)2C6H4}(L24)] in the crystal of 74, (c) Rh(phpy)2(L24) (75), and (d) (PMe3)2Rh(X2)(L24) (77). In (b), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity.
Inorganics 09 00060 g007
Inorganics 09 00060 g008 550
Figure 8. Molecular structures of palladium complexes: (a) Pd(L13)2 (81), (b) Pd2(L86)2 in the crystal of 100, (c) [Pd2(L44)2]2+ in 102, (d) (fcdpm)Pd(L43) (105), (e) {[(PPh3)2Pd]2(L85)}2+ in 113, and (f) (PPh3)Pd(L81)Cl in 122. In (c,e), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity.
Figure 8. Molecular structures of palladium complexes: (a) Pd(L13)2 (81), (b) Pd2(L86)2 in the crystal of 100, (c) [Pd2(L44)2]2+ in 102, (d) (fcdpm)Pd(L43) (105), (e) {[(PPh3)2Pd]2(L85)}2+ in 113, and (f) (PPh3)Pd(L81)Cl in 122. In (c,e), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity.
Inorganics 09 00060 g008
Inorganics 09 00060 g009 550
Figure 9. Molecular structures of palladium complexes: (a) [tBu(Ph)POH][tBu(Ph)P(=O)]Pd(L24) (147), (b) Cu{[tBu(PhP)(O)]Pd(L24)}2 (148), (c) Pd(X3)(L24) in 152, (d) (PPh3)Pd(pyr)(L57) (154), and (e) Pd(η3-C4H7)(L8) (155). In (b), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity.
Figure 9. Molecular structures of palladium complexes: (a) [tBu(Ph)POH][tBu(Ph)P(=O)]Pd(L24) (147), (b) Cu{[tBu(PhP)(O)]Pd(L24)}2 (148), (c) Pd(X3)(L24) in 152, (d) (PPh3)Pd(pyr)(L57) (154), and (e) Pd(η3-C4H7)(L8) (155). In (b), only the ispo-C atoms of the phosphane bound phenyl rings are shown for clarity.
Inorganics 09 00060 g009
Inorganics 09 00060 g010 550
Figure 10. Molecular structures of osmium complexes: (a) Os(L8)2(CO)2 (157), (b) (PPh3)2Os(SiCl3)(L8)(CO) in the crystal of 158, (c) (PPh3)2Os(SnMe2SnPh3)(L8)(CO) in 170, (d) Os3(L8)2(CO)10 (173), (e) Os4(L8)2(CO)12(CO2)(S) in 174, and (f) Os3(H)(L24)(CO)9 (176).
Figure 10. Molecular structures of osmium complexes: (a) Os(L8)2(CO)2 (157), (b) (PPh3)2Os(SiCl3)(L8)(CO) in the crystal of 158, (c) (PPh3)2Os(SnMe2SnPh3)(L8)(CO) in 170, (d) Os3(L8)2(CO)10 (173), (e) Os4(L8)2(CO)12(CO2)(S) in 174, and (f) Os3(H)(L24)(CO)9 (176).
Inorganics 09 00060 g010
Inorganics 09 00060 g011 550
Figure 11. Molecular structures of iridium dithiocarbamate complexes: (a) Ir(ppy)2(L24) (177), (b) (PPh3)2Ir(C5H5SMe)(L24) (199), (c) [Cp*Ir(L24)]22+ in the crystal of 204, (d) Cp*Ir(mtz)(L8) in 205, (e) [{Cp*Ir(L8)}2(mtz)]+ in 206, (f) Cp*Ir(PMe3)(L5)(SH) in 207, and (g) Cp*Ir(H)(PMe3)(L5) (208). In (d) and (f), the blue dashed line represents N–H…N and N–H…S hydrogen bonds, respectively.
Figure 11. Molecular structures of iridium dithiocarbamate complexes: (a) Ir(ppy)2(L24) (177), (b) (PPh3)2Ir(C5H5SMe)(L24) (199), (c) [Cp*Ir(L24)]22+ in the crystal of 204, (d) Cp*Ir(mtz)(L8) in 205, (e) [{Cp*Ir(L8)}2(mtz)]+ in 206, (f) Cp*Ir(PMe3)(L5)(SH) in 207, and (g) Cp*Ir(H)(PMe3)(L5) (208). In (d) and (f), the blue dashed line represents N–H…N and N–H…S hydrogen bonds, respectively.
Inorganics 09 00060 g011
Inorganics 09 00060 g012 550
Figure 12. Molecular structures of platinum dithiocarbamate complexes: (a) Pt(L52)2 (222) and (b) Pt(L62)2 (228), and coordination polymers in (c) [Zn(H2O)4Pt(L17)2]n in the crystal of 229 and (d) {[Zn(H2O)4]2Pt(L51)2}n in 232.
Figure 12. Molecular structures of platinum dithiocarbamate complexes: (a) Pt(L52)2 (222) and (b) Pt(L62)2 (228), and coordination polymers in (c) [Zn(H2O)4Pt(L17)2]n in the crystal of 229 and (d) {[Zn(H2O)4]2Pt(L51)2}n in 232.
Inorganics 09 00060 g012
Inorganics 09 00060 g013 550
Figure 13. Molecular structures of platinum dithiocarbamate complexes: (a) [Pt(L57)Cl]5 in the crystal of 233, (b) (PPh3)Pt(η1-L57)(η2-L57) in 234, (c) {[(PEt3)2Pt]2(L74)}2+ in 235, (d) Pt(L57)Cl((CH3)2SO) (237), and (e) (PEt3)Pt(L24)Cl (238).
Figure 13. Molecular structures of platinum dithiocarbamate complexes: (a) [Pt(L57)Cl]5 in the crystal of 233, (b) (PPh3)Pt(η1-L57)(η2-L57) in 234, (c) {[(PEt3)2Pt]2(L74)}2+ in 235, (d) Pt(L57)Cl((CH3)2SO) (237), and (e) (PEt3)Pt(L24)Cl (238).
Inorganics 09 00060 g013
Inorganics 09 00060 g014 550
Figure 14. Molecular structures of platinum dithiocarbamate complexes: (a) Pt(bmi)(L24)I (244), (b) (Pt(bzq)(L8) (245), (c) [Pt(L24)]2(bpy) in the crystal of 248, (d) (PEt3)Pt(L24)(CH2(iPr)) (249), (e) Pt(bzq)(L8)(PPh2)2Pt(C6F5)2 (251), and (f) the coordination polymer {Ag[Pt(bzq)(L57)]2}n in 252. In (f), only the atoms forming the chelate ring formed by the benzo[h]quinolin-10-yl ligand are shown.
Figure 14. Molecular structures of platinum dithiocarbamate complexes: (a) Pt(bmi)(L24)I (244), (b) (Pt(bzq)(L8) (245), (c) [Pt(L24)]2(bpy) in the crystal of 248, (d) (PEt3)Pt(L24)(CH2(iPr)) (249), (e) Pt(bzq)(L8)(PPh2)2Pt(C6F5)2 (251), and (f) the coordination polymer {Ag[Pt(bzq)(L57)]2}n in 252. In (f), only the atoms forming the chelate ring formed by the benzo[h]quinolin-10-yl ligand are shown.
Inorganics 09 00060 g014
Inorganics 09 00060 g015 550
Figure 15. The mean and 95% range (two standard deviations) for the 1H chemical shifts reported for α-hydrogen nuclei.
Figure 15. The mean and 95% range (two standard deviations) for the 1H chemical shifts reported for α-hydrogen nuclei.
Inorganics 09 00060 g015
Inorganics 09 00060 g016 550
Figure 16. L- and D-forms of [M(L-L)3].
Figure 16. L- and D-forms of [M(L-L)3].
Inorganics 09 00060 g016
Inorganics 09 00060 g017 550
Figure 17. Correlation of νC–N with the barrier to C–N bond rotation.
Figure 17. Correlation of νC–N with the barrier to C–N bond rotation.
Inorganics 09 00060 g017
Table
Table 1. List of dithiocarbamates L1 to L56.
Table 1. List of dithiocarbamates L1 to L56.
−S2CNRR′
LigandRR′
L1HH
L2HMe
L3HEt
L4HPh
L5Hp-tolyl
L6HC6H4Et-p
L7HC6H4Cl-p
L8MeMe
L9MeCH2C≡CH
L10MeCH2CH=CH2
L11Men-Bu
L12Men-Hex
L13MeCH2Ph
L14MePh
L15MeCy
L16MeCH2CH(OMe)2
L17MeCH2COO−
L18MeCH2COOH
L19MeCH2COOMe
L20MeCH2COOEt
L21MeCH2COO-t-Bu
L22MeCH2CH2OC(=O)CH=CHCOOEt
L23Me2-methyl-1,3-dioxolane
L24EtEt
L25EtCH2CH2OH
L26CH2CH2OMeCH2CH2OMe
L27CH2CH=CH2CH2CH=CH2
L28n-Prn-Pr
L29i-Pri-Pr
L30(CH2)3NMe2(CH2)3NMe2
L31n-Bun-Bu
L32n-BuCH2Ph
L33n-BuPh
L34CH2(i-Pr)CH2(i-Pr)
L35n-Hexn-Hex
L36n-Decn-Dec
L37CH2CH(Me)(Et)CH2CH(Me)(Et)
L38CH2CH(Et)(n-Bu)CH2CH(Et)(n-Bu)
L39CH2PhCH2Ph
L40CH2PhCH2C6H4OMe-3
L41CH2PhCH2C5H4N-3
L42CH2PhCH2C4H3NMe
L43CH2PhCH2C5H4FeCp
L44(CH2)2PPh2(CH2)2PPh2
L45C5H4N-2C5H4N-2
L46PhPh
L47CyCy
L48p-tolylp-tolyl
L49C6H4CF3-pC6H4CF3-p
L50C6H4(t-Bu)-pC6H4(t-Bu)-p
L51CH2COO−CH2COO−
L52CH2COOHCH2COOH
L53CH2COOHCH2COO−
L54CH2C4H3OCH2C4H3O
L55CH2C6H4OH-op-tolyl
L56CH2C(=O)N(H)(CH2)3CH3CH2C(=O)N(H)(CH2)3CH3
Table
Table 2. Summary of ruthenium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
Table 2. Summary of ruthenium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
CrystalFormulationREFCODEDonor SetRef.
1Ru(L8)3OCOVUZS6[25]
2Ru(L20)3OCOWEKS6[25]
3[Ru(L57)3], CHCl3OCOWAGS6[25]
4[Ru2(L8)5]BF4, CHCl3, CH3CNREDCEKS6[32]
5[Ru2(L8)5]{[Mo6O19]0.5}, CH3COCH3YUJFOZS6[33]
6Ru(L8)2((CH3)2SO)2REDBUZcis-O2S4[32]
7Ru(L57)2((CH3)2SO)2REDCAGcis-O2S4[32]
8(dppb)Ru(L24)2EBESOWcis-P2S4[34]
9[(dppb)Ru(L63)2], CH2Cl2PAZWODcis-P2S4[35]
10(dppb)Ru(L79)2EBESIQcis-P2S4[34]
11[Ru(bpy)2(L8)]PF6, 0.75((CH3CH2)2O)DANDOMN4S2[36]
12[Ru(bpy)2(L56)]PF6WOHLAHN4S2[37]
13[Ru(cyclam)(L24)]BPh4, 0.16(CH2Cl2)BUPMEFN4S2[38]
14[(dppm)2Ru(L9)]PF6, 0.5(CH2Cl2)COZMIPP4S2[39]
15[(dppm)2Ru(L26)]PF6HUYPATP4S2[40]
16{[(dppm)2Ru]2(L74)}[BF4]2, 3(CHCl3)QAVHAXP4S2[41]
17[(dppm)2Ru(L74)Pd(PPh3)2][BF4]2, 3(CH2Cl2), (CH3CH2)2OQONVARP4S2[42]
18(PPh3)2Ru(L8)Cl2, 2(CH2Cl2)HUPMAHCl2P2S2[43]
19(PPh3)2Ru(L24)Cl2, CH2Cl2GUVPIXCl2P2S2[44]
20(PPh3)2Ru(L29)Cl2, CH2Cl2GUVPODCl2P2S2[44]
21[(PPh3)Ru(tptz)(L24)]Cl, 2.5(H2O)ABIBETN3PS2[45]
22(PEt3)Ru(L8)2(CO)PEBZUSCPS4[46]
23(PPh3)Ru{Ge(p-tolyl)2}(L8)2(CO), CH2Cl2VEKKIHCGePS3[47]
24(PPh3)Ru(κ2(Si,N)-SiPh2NHC5H4N)(L8)(CO)RADNIUCNPS2Si[48]
25(PPh3)Ru(κ2(Si,N)-SiPh2OC5H4N)(L8)(CO), 2.5(C6H6)RADNEQCNPS2Si[48]
26(PPh3)Ru(κ2(Si,O)-SiPh2OCCH3O)(L8)(CO), CH2Cl2RADNOACNPS2Si[48]
27Ru(B(NCH2PPh2)2C6H4)(L24)(CO)UNAVEMBCP2S2[49]
28(PPh3)2Ru(H)(L7)(CO), 0.5(CH3(CH2)4CH3)OWOKERCHP2S2[50]
29(PPh3)2Ru(H)(L8)(CO)RADMUFCHP2S2[48]
30(PPh3)2Ru(H)(L84)(CO)YOSJEXCHP2S2[51]
31(PPh3)2Ru(Si(Cl)Ph2)(L8)(CO)RADNAMCP2S2Si[48]
32(PPh3)2Ru(Ge(p-tolyl)3)(L24)(CO), 1.19(CH2Cl2)VEKKAZCGeP2S2[47]
33(PPh3)2Ru(C(H)=C(H)BMIDA)(L24)(CO), CH3COCH3HUDPONC2P2S2[52]
34(PPh3)2Ru(C(H)=C(H)C6H4Me-4)(L10)(CO), CH2Cl2COZMELC2P2S2[39]
35(PPh3)2Ru(C(H)=C(H)C6H4Me-4)(L26)(CO), 0.3(CH2Cl2)HUYPEXC2P2S2[40]
36(PPh3)2Ru(C(H)=C(H)C6H4Me-4)(L27)(CO), CH2Cl2OJEYIMC2P2S2[53]
37(PPh3)2Ru(C(H)=C(H)pyrenyl-1)(L84)(CO), 1.5(CH2Cl2)YOSJIBC2P2S2[51]
38(PPh3)2Ru(C(C≡C(Ph)=C(H)Ph)(L84)(CO)YOSJOHC2P2S2[51]
39(PPh3)2Ru(C(C≡CSiMe3)=C(H)SiMe3)(L8)(CO), unknown solvateKOQPEOC2P2S2[54]
40[(PPh3)2Ru(C(C≡CPh)=C(H)Ph)(L65)(CO)]Cl, 1.25(CH2CH2OH)DOZHOQC2P2S2[55]
41(PPh3)2Ru(C≡CBMIDA)(L8)(CO)HUDPAZC2P2S2[52]
42(PPh3)2Ru(C≡CBMIDA)(L24)(CO), 0.5(CH2Cl2), unknown solvateHUDPEDC2P2S2[52]
43(PPh3)2Ru(X)(L24)(CO)BOHTOKC2P2S2[56]
44(PPh3)2Ru(L24)(CO)Cl, 2.5(C6H6)HUDQAACClP2S2[52]
45(PPh3)2Ru(L24)(CO)Cl, CH2Cl2HUDQEECClP2S2[52]
46(PPh3)2Ru(L24)(CO)Cl, 2(CHCl3), unknown solvateHUDQIICClP2S2[52]
47(PPh3)2Ru(L24)(CO)Cl, CH3OHHUDQOOCClP2S2[52]
48(PPh3)Ru(Ge(p-tolyl)3)(L24)(CO)2VEKKEDC2GePS2[47]
49Ru(L22)(CO)3ClROQQUMfac-C3ClS2[57]
50CpRu(PPh3)(L11)YEDMEAC3PS2[58]
51CpRu(PPh3)(L24)KEZVOBC3PS2[59]
52CpRu(PPh3)(L28)YEDMAWC3PS2[58]
53CpRu(PPh3)(L57)BUYQIWC3PS2[60]
54{[CpRu(L24)]2(dppf)}, CH2Cl2IZIBAUC3PS2[61]
55CpRu(L8)(CO)QIWNESC4S2[62]
56[Cp*Ru(L8)2][N(S=PPh2)2], 0.5(H2O)PARVUAC3S4[63]
57[Cp*Ru(L8)(L24)]Cl, 2CHCl3TEYTEXC3S4[64]
58Cp*Ru(L8)Cl2WEYTUQC3Cl2S2[65]
59Cp*Ru(L24)Cl2TEYSUMC3Cl2S2[64]
60Cp*Ru(S2C=O)(L8)TEYTIBC3S4[64]
61Cp*Ru(S2C=O)(L24)TEYTOHC3S4[64]
62[Cp*Ru(PPh3)(L8)Cl]Cl, 0.5(H2O), 1.5(CH3CN)TEYTUNC3ClPS2[64]
63[Cp*Ru(PMe3)(L8)Cl]BPh4TEYVAVC3ClPS2[64]
64[Cp*Ru(L8)Cl]2[SbCl6]2WEYVECC3Cl2S2[65]
65[Cp*Ru(L8)(CH3CN)2][PF6]2, 2CH3CNWEYVAYC3N2S2[65]
66Cp*Ru(L8)(CO)TEYVIDC4S2[64]
67[(PPh3)2Ru(C(NMe2)OC(NMe2)=S)(L8)]ClO4HUPMELCP2S3[43]
68[(PPh3)2Ru(C(NMe2)SC(NMe2)=S)(L8)]ClO4, 2(CH2Cl2)HUPLUACP2S3[43]
69Ru(X1)(L8)ClIQUFEGC4ClS2[66]
70Ru(X1)(L29)ClIQUFIKC4ClS2[66]
71[Ru(X1)(L8)(CH3CN)]PF6IQUFOQC4NS2[66]
72(p-cymene)Ru(L79)ClPEKVINC3ClS2[67]
Table
Table 3. Summary of rhodium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
Table 3. Summary of rhodium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
CrystalFormulationREFCODEDonor SetRef.
73Tp*Rh(η2-L24)(η1-L24)BILHION3S3[68]
74[Rh(H){κ3-P,Si,P′-SiPh(NCH2PPh2)2C6H4}(L24)], 0.5(C6H6)WODHOOHP2S2Si[69]
75Rh(phpy)2(L24)EMOKAUC2N2S2[70]
76Rh(phpy)2(L66)XOCFUSC2N2S2[71]
77(PMe3)2Rh(X2)(L24)KUPVOHC2P2S2[72]
Table
Table 4. Summary of palladium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
Table 4. Summary of palladium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
CrystalFormulationREFCODEDonor SetRef.
78Pd(L4)2YIRSIES4[73]
79Pd(L8)2OMUJEN01 *S4[74,75,76]
80Pd(L11)2ODOYAIS4[77]
81Pd(L13)2LIGSAWS4[78]
82Pd(L15)2ZOJVAXS4[79]
83Pd(L16)2FUHXENS4[80]
84Pd(L24)2DETCPD02S4[81]
85Pd(L25)2FEVCERS4[82]
86Pd(L30)2QOWXUWS4[83]
87Pd(L33)2EMOKOIS4[84]
88Pd(L35)2ZOJTUPS4[79]
89Pd(L39)2LIGSEAS4[78]
90Pd(L39)2, C5H5NZOJTIDS4[79]
91Pd(L39)2, 2Cr(C6H6)2, 2(C60)CEBCESS4[85]
92Pd(L41)2HOMXEOS4[86]
93Pd(L42)2LUKTESS4[87]
94Pd(L47)2, C5H5NZOJTOJS4[79]
95Pd(L57)2UBIFUIS4[88]
96Pd(L63)2XAZZOOS4[89]
97Pd(L64)2JESJUNS4[90]
98[Pd(L66)2], 3H2OBEZKAUS4[91]
99Pd2(L86)2KENYINS4[92]
100Pd2(L86)2, CHCl3KENYOTS4[92]
101Pd2(L87)2, 2(CH3OH)IXIWANS4[93]
102[Pd2(L44)2]Cl2, 1.5(CH3OH), 2(H2O)IGUBAPP2S2[94]
103(fcdpm)Pd(L24)YEFVOWN2S2[95]
104(fcdpm)Pd(L29)YEFVUCN2S2[95]
105(fcdpm)Pd(L43)VIZJOFN2S2[96]
106[Pd(dmbp)(L75)][PF6]2XEDWOVN2S2[97]
107[Pd(bpy)(L75)][PF6]2, CH3CNXEDWUBN2S2[97]
108[(dppe)Pd(L57)]Cl, 1.33(H2O), CHCl3DIFQIUP2S2[26]
109[(dppp)Pd(L24)]BF4, 2(CHCl3)WUMQEBP2S2[98]
110[(dppf)Pd(L57)]PF6, CH2Cl2DOZKOVP2S2[99]
111{[(PPh3)2Pd]2(L74)}[PF6]2, (CH3CH2)2OKEKKAPP2S2[100]
112{[(PPh3)2Pd]2(L74)}[PF6]2, (CH3CH2)2OKEKKETP2S2[100]
113{[(PPh3)2Pd]2(L85)}[PF6]2, (CH3CH2)2OKEKKIXP2S2[100]
114{[(dppf)Pd]2(L74)}[BF4]2, 2.6(CH2Cl2)RUDLEIP2S2[101]
115{[(dppf)Pd]2(L85)}[PF6]2, CH2Cl2, CH3CH2OHISEWINP2S2[102]
116(PPh3)Pd(L31)ClRASYANClPS2[103]
117(PPh3)Pd(L32)ClNAJVECClPS2[104]
118(PPh3)Pd(L47)ClKIJROLClPS2[105]
119(PPh3)Pd(L57)Cl, 0.5(CHCl3) DICXOEClPS2[26]
120(PPh3)Pd(L64)ClSAYZOIClPS2[106]
121(PPh3)Pd(L68)Cl, 0.5(CHCl3) NAJNOEClPS2[104]
122(PPh3)Pd(L81)ClBULBAMClPS2[107]
123[P(o-tolyl)3]Pd(L81)ClBUKZUD *ClPS2[107,108]
124[P(p-tolyl)3]Pd(L39)ClVANWALClPS2[109]
125[P(p-tolyl)3]Pd(L69)ClROHJUWClPS2[110]
126[P(p-tolyl)3]Pd(L71)Cl, CHCl3UNOYAZClPS2[111]
127[P(p-tolyl)3]Pd(L76)ClROHKADClPS2[110]
128[P(C6H4Cl-p)3]Pd(L69)ClADUHALClPS2[112]
129[P(C6H4Cl-p)3]Pd(L72)ClMEHHITClPS2[113]
130[P(C6H4Cl-p)3]Pd(L77)ClQEKTAEClPS2[114]
131[P(C6H4F-p)]Pd(L69)ClADUGOYClPS2[112]
132[P(C6H4F-p)]Pd(L71)ClADUGUEClPS2[112]
133[P(C6H4F-p)]Pd(L72)ClMEHHEPClPS2[113]
134[P(C6H4F-p)]Pd(L77)Cl} 0.5(CH3COCH3) QEKSUXClPS2[114]
135[PPh2(o-tolyl)]Pd(L71)ClGIQGUKClPS2[115]
136[PPh2(p-tolyl)]Pd(L31)ClRASYERClPS2[103]
137[PPh2(p-tolyl)]Pd(L39)ClVANVUEClPS2[109]
138[PPh2(p-tolyl)]Pd(L67)ClVANVOYClPS2[109]
139[PPh2(p-tolyl)]Pd(L69)ClROHJOQClPS2[110]
140[PPh2(p-tolyl)]Pd(L71)ClUNOYONClPS2[111]
141[PPh2(C6H4OMe-o)]Pd(L24)Cl, H2O RAFLERClPS2[116]
142[PPh2(nPr)]Pd(L26)ClEHOBOUClPS2[117]
143[PPh2(tBu)]Pd(L38)ClEHOBUAClPS2[117]
144[PPh2(CH2Ph)]Pd(L8)ClRAFLANClPS2[116]
145[PPh2(CH2Ph)]Pd(L24)ClGIQHARClPS2[115]
146[(PPh3)Pd(L68)(SCN)], 0.5(CH2Cl2)NAJNIYPS3[104]
147[tBu(Ph)POH][tBu(Ph)P(=O)]Pd(L24)SAGBIMP2S2[118]
148Cu{[tBu(PhP)(O)]Pd(L24)}2SAFZUVP2S2[118]
149Pd(phpz)(L24)UMEBEUCNS2[119]
150Pd(phpy)(L63)JUPNITCNS2[120]
151Pd(C^N)(L24)OVEPOVCNS2[121]
152Pd(X3)(L24), CH3(CH2)4CH3, 0.5(CH2Cl2)FOHYEHCNS2[122]
153Pd(κ2-C,N-CH2SiPh2(CH2NC5H10))(L24)EZEXIQCNS2[123]
154(PPh3)Pd(pyr)(L57)UQANEGCPS2[124]
155Pd(η3-C4H7)(L8)ODOXOVC2S2[77]
156Pd(η3-C4H7)(L28)ODOYEMC2S2[77]
* CSD depositions are available for repeated measurements.
Table
Table 5. Summary of osmium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
Table 5. Summary of osmium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
CrystalFormulationREFCODEDonor SetRef.
157Os(L8)2(CO)2KAZHIEC2S4[130]
158(PPh3)2Os(SiCl3)(L8)(CO), 2(CH2Cl2)NEKGOACP2S2Si[125]
159(PPh3)2Os(SiMeCl2)(L8)(CO), 2(CH2Cl2)NEKGIUCP2S2Si[125]
160(PPh3)2Os(SiMe2Cl)(L8)(CO), CH2Cl2FIXRAGCP2S2Si[126]
161(PPh3)2Os(SiMe2OH)(L8)(CO), x(CH3(CH2)5CH3)FIXREKCP2S2Si[126]
162(PPh3)2Os(SiMe2OSiMe3)(L8)(CO)FIXROUCP2S2Si[126]
163(PPh3)2Os(SiOH3)(L8)(CO)FIXRIOCP2S2Si[126]
164(PPh3)2Os(SnCl3)(L8)(CO), CHCl3QEWPAKCP2S2Sn[127]
165(PPh3)2Os(SnF3)(L8)(CO), 2(CH2Cl2)QEWPEOCP2S2Sn[127]
166(PPh3)2Os(SnH3)(L8)(CO), C6H6QEWNUCCP2S2Sn[127]
167(PPh3)2Os(SnHMe2)(L8)(CO), C6H6QEWPUECP2S2Sn[127]
168(PPh3)2Os(SnMeF2)(L8)(CO), CH2Cl2QEWPOYCP2S2Sn[127]
169(PPh3)2Os(SnMe2Cl)(L8)(CO), C6H6TAXYOHCP2S2Sn[128]
170(PPh3)2Os(SnMe2SnPh3)(L8)(CO), 2(CH2Cl2)PENLIECP2S2Sn[129]
171(PPh3)Os(SnMe2C6H4PPh2)(L8)(CO)TAXYUNCP2S2Sn[128]
172(PPh3)Os(SnMeClC6H4PPh2)(L8)(CO)TAXZAUCP2S2Sn[128]
173Os3(L8)2(CO)10KUJFEDC3OsS2[131]
174[Os4(L8)2(CO)12(CO2)(S)], 2(CH2Cl2)KUJFIHC3OS2, C3S3[131]
175Os3(H)(L8)(CO)9KUJFUTC3Os2S/C3HOs2S[131]
176Os3(H)(L24)(CO)9SATGUQC3Os2S/C3HOs2S[132]
Table
Table 6. Summary of iridium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
Table 6. Summary of iridium dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
CrystalFormulationREFCODEDonor SetRef.
177Ir(ppy)2(L24)WIHPUZC2N2S2[133]
178Ir(buppy)2(L24)MADKAEC2N2S2[134]
179Ir(pba)2(L24)QOFTENC2N2S2[135]
180Ir(tfmppy)2(L29)FODDUAC2N2S2[136]
181Ir(btfmppy)2(L29)FODDOUC2N2S2[136]
182Ir(tfmbpy)2(L29)FODFAIC2N2S2[136]
183Ir(tfmpiq)2(L29)HOFCUDC2N2S2[137]
184Ir(tfmpiq)2(L46), unknown solvateHOFDAKC2N2S2[137]
185Ir(tfmpiq)2(L83), unknown solvateHOFDEOC2N2S2[137]
186Ir(pqz)2(L82)ZUQLUUC2N2S2[27]
187Ir(tfmpqz)2(L29)LIYWUOC2N2S2[138]
188Ir(tfmpqz)2(L46)CUMGUPC2N2S2[139]
189Ir(tfmpqz)2(L48)CUMGOJC2N2S2[139]
190Ir(tfmpqz)2(L49)CUMHOKC2N2S2[139]
191Ir(tfmpqz)2(L50)VIWDAJC2N2S2[140]
192Ir(tfmpqz)2(L82)LIYWOIC2N2S2[138]
193Ir(tfmpqz)2(L83)VIWCUCC2N2S2[140]
194Ir(dpp)2(L24), CH2Cl2, unknown solvateIQAFENC2N2S2[141]
195Ir(dpci)2(L82), CH2Cl2, 1.5(H2O)VITHENC2N2S2[142]
196Ir(pbt)2(L24)IXOJEM *C2N2S2[143,144]
197Ir(ptbt)2(L24)WOTQUUC2N2S2[145]
198Ir(X4)2(L24), 0.5(H2O)WEKROU *C2N2S2[146,147]
199(PPh3)2Ir(C5H5SMe)(L24)ANOKAQC2P2S2[148]
200[(PPh3)2Ir(C5H4SMe)(L24)]PF6ANOJUJC2P2S2[148]
201[(PPh3)2Ir(C5H3Me-3SMe)(L24)]PF6, ClCH2CH2ClANOKEUC2P2S2[148]
202[(PPh3)2Ir(C5H3OEt-3SMe)(L24)]PF6ANOKIYC2P2S2[148]
203[Cp*Ir(L24)(CO)]CF3SO3GEVGUKC4S2[149]
204[Cp*Ir(L24)]2[ClO4]2WIHNILC3S3[150]
205Cp*Ir(mtz)(L8), 5-methyltetrazoleNOJPUYC3NS2[151]
206[{Cp*Ir(L8)}2(mtz)]PF6NOJQAFC3NS2[151]
207Cp*Ir(SH)(PMe3)(L5), CH2Cl2SIKPUYC3PS2[152]
208Cp*Ir(H)(PMe3)(L5)SIKQEJC3HPS[152]
209[Cp*Ir(PPh3)(L24)]3[Cp*Ir(PPh3)(L25)(NCH3)][I]4OYUJEYC3NPS[153]
* CSD depositions are available for repeated measurements.
Table
Table 7. Summary of platinum dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
Table 7. Summary of platinum dithiocarbamate structures established by X-ray crystallography. See Table 1, Figure 2, and the Abbreviations section.
CrystalFormulationREFCODEDonor SetRef.
210Pt(L4)2YIRSOKS4[73]
211Pt(L6)2YIRXEFS4[73]
212Pt(L8)2TEDRIG *S4[75,76]
213Pt(L16)2FUHXIRS4[80]
214Pt(L27)2TUCMAHS4[154]
215Pt(L29)2LOWJEPS4[155]
216[Pt(L31)2], C60MOKNORS4[156]
217Pt(L33)2EMOKUOS4[84]
218Pt(L34)2ZOJHUES4[155,157]
219[Pt(L39)2], C6H5CNZOJJAMS4[157]
220Pt(L41)2LASPIHS4[158]
221Pt(L45)2UHOGIJS4[159]
222Pt(L52)2MOHNUUS4[160]
223[Pt(L52)2], 6((CH3)2SO)GUCQAZS4[161]
224Pt(L54)2HOMXAKS4[86]
225Pt(L55)2, unknown solvateGUMCEZS4[162]
226Pt(L70)2WIFVUFS4[163]
227Pt(L80)2CAJWOCS4[164]
228Pt(L62)2GEZHEAS3N[165]
229[Zn(H2O)4Pt(L17)2]n, 4(H2O)GUCQEDS4[161]
230[Zn(H2O)4Pt(L58)2]n, 2(H2O)GUCQIHS4[161]
231{Zn(H2O)3Pt(L53)2]n, 3(H2O)GUCQUTS4[161]
232{[Zn(H2O)4]2Pt(L51)2}n, 6(H2O)GUCQONS4[161]
233[Pt(L57)Cl]5, 2(ClCH2CH2Cl)HACCARClS3[166]
234(PPh3)Pt(η1-L57)(η2-L57), 2(CH2Cl2), 0.25(CH3(CH2)3CH3)DIFQOAPS3[26]
235{[(PEt3)2Pt]2(L74)}(PF6)2, unknown solvateRUDLAEP2S2[101]
236{[(PPh3)2Pt]2(L74)}(PF6)2RUDKUXP2S2[101]
237Pt(L57)(Cl)((CH3)2SO)NASDAOClS3[167]
238(PEt3)Pt(L24)ClTOWNURClPS2[168]
239(PPh3)Pt(L57)Cl, 0.5(CH2Cl2)HACBUKClPS2[166]
240[P(C6H4Cl-p)3]Pt(L73)ClAZIDAQClPS2[169]
241[P(C6H4F-p)3]Pt(L73)ClAZIDEUClPS2[169]
242[P(C6H4F-p)3]Pt(L78)ClAZICUJClPS2[169]
243[P(p-tolyl)3]Pt(L76)ClRIZNEWClPS2[170]
244Pt(bmi)(L24)IAHADARCIS2[171]
245Pt(bzq)(L8)EQONOOCNS2[172]
246Pt(bzq)(L57)EQONIICNS2[172]
247Pt(X5)(L24)PUPHUFCNS2[173]
248[Pt(L24)]2(bpy), CH2Cl2RIZBUACNS2[174]
249(PEt3)Pt(L24)(CH2(iPr))HUWGIRCPS2[175]
250Pt(PPh3)(L24)C≡W(CO)2(Tp*)JUQRARCPS2[176]
251Pt(bzq)(L8)(PPh2)2Pt(C6F5)2, 2(CH2Cl2)QUFXATCNP2S2[177]
252{Ag[Pt(bzq)(L57)]2}n, n(ClO4), n(CH3CN)EQOPEGAgCNS2[172]
* CSD depositions are available for repeated measurements.
Table
Table 8. The mean 1H chemical shifts reported for α-hydrogen nuclei and the standard deviation of these shifts as a function of the metal ion.
Table 8. The mean 1H chemical shifts reported for α-hydrogen nuclei and the standard deviation of these shifts as a function of the metal ion.
Metal IonMean Shift, ppmSample Standard Deviation, ppm
Ru(II)3.200.50
Ru(III)3.630.37
Os(II)2.470.63
Rh(III)3.630.37
Ir(III)3.290.44
Pd(II)3.820.61
Pt(II)3.830.50
Pt(IV)3.510.26
Table
Table 9. 1H Chemical shifts of α-hydrogen nuclei for a series of ruthenium(III) dithiocarbamate complexes.
Table 9. 1H Chemical shifts of α-hydrogen nuclei for a series of ruthenium(III) dithiocarbamate complexes.
Complexδ, ppmRef.
[Ru(L8)3] 28.85[25]
28.70[32]
[Ru(L57)3] 45.03, 36.28[25]
44.40, 36.00[32]
[Ru(L19)3]26.80, 26.70, 21.83, 14.63[25]
[Ru(L20)3]26.70, 26.23, 21.92, 14.55[25]
[Ru(L21)3] 26.82, 26.43, 21.32, 14.40[25]
α-[Ru2(L8)5]Cl 3.55, 3.52, 3.50, 3.20, 2.99[25]
3.62, 3.46, 3.47, 3.17, 2.93[32]
β-[Ru2(L8)5]Cl 3.55, 3.54, 3.51, 3.20, 3.19[32]
α-[Ru2(L57)5]Cl 4.05–3.37[25]
4.25–3.15[32]
β-[Ru2(L57)5]Cl 3.98–3.40[32]
α-[Ru2(L19)5]Cl4.60–4.00, 3.48–3.14[25]
β-[Ru2(L20)5]Cl5.14–4.45, 3.71–3.04[25]
α-[Ru2(L21)5]Cl 4.72–4.01, 3.64–2.62[25]
Table
Table 10. Contemporary data for the barrier to rotation about the C–N bonds of platinum-group metal complexes.
Table 10. Contemporary data for the barrier to rotation about the C–N bonds of platinum-group metal complexes.
ComplexΔG, kJ mol−1ν(C–N), cm−1Ref.
[Ru(CO)2(L8)2] 78 ± 1Not reported[182]
[Ru(CO)(PEt3)(L8)2] 74 ± 1 and 71 ± 1Not reported[46]
[Os(CO)2(L8)2] 74.2 ± 0.5Not reported[130]
[{PtMe3(L1)}2] 71.43 ± 0.141609[178]
[{PtMe3(L8)}2] 81.54 ± 0.191530[178]
[{PtMe3(L24)}2] 82.89 ± 0.561516[178]
[{PtMe3(L2)}2] 72.27 ± 0.051517[178]
[{PtMe3(L3}2] 66.36 ± 0.051518[178]
[{PtMe3(L4)}2] 65.61 ± 0.011527[178]
[{PtMe3(L14)}2] 86.54 ± 0.29
87.24 ± 0.27
87.15 ± 0.35		1489[178]
Table
Table 11. 195Pt NMR data reported for selected Pt(II) and Pt(IV) dithiocarbamate complexes.
Table 11. 195Pt NMR data reported for selected Pt(II) and Pt(IV) dithiocarbamate complexes.
Complex δ, ppm aδ, ppm bRef.
[Pt(pbt)(L24)]686-[143]
[Pt(L18) 2]626-[161]
[Pt(L59)2]720-[161]
Zn[Pt(L58)2]793-[161]
[Pt(L52)2]603-[161]
Zn[Pt(L53)2]614-[161]
Zn2[Pt(L51)2]678-[161]
[WPt(μ-C)(L24)(CO)2(PPh3)(Tp*)]694-[176]
[Pt(pmea)(L24)]810-[173]
[PtMeI(pmea)(L24)]1333-[173]
[{PtMe3(L1)}2]1416-[178]
[{PtMe3(L8)}2]1577-[178]
[{PtMe3(L24)}2]1564-[178]
[{PtMe3(L2)}2]1623, 1609, 1598, 1587-[178]
[{PtMe3(L3}2]1626, 1609, 1607, 1596-[178]
[{PtMe3(L4}2]1632, 1600, 1587, 1582-[178]
[{PtMe3(L14)}2]1584, 1575, 1569, 15591601[178]
a Spectra recorded at ambient temperature in solution. Chemical shifts quoted relative to the absolute frequency scale Ξ(195Pt) = 21.4 MHz, and, where appropriate, have been converted from originally published data: δ[PtCl6]2− + 4522 = Ξ(195Pt). Conversion factor is taken from [184]. b Solid-state NMR, recorded at ambient temperature. Chemical shifts quoted relative to the absolute frequency scale Ξ(195Pt) = 21.4 MHz.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tan, Y.S.; Yeo, C.I.; Tiekink, E.R.T.; Heard, P.J. Dithiocarbamate Complexes of Platinum Group Metals: Structural Aspects and Applications. Inorganics 2021, 9, 60. https://0-doi-org.brum.beds.ac.uk/10.3390/inorganics9080060

AMA Style

Tan YS, Yeo CI, Tiekink ERT, Heard PJ. Dithiocarbamate Complexes of Platinum Group Metals: Structural Aspects and Applications. Inorganics. 2021; 9(8):60. https://0-doi-org.brum.beds.ac.uk/10.3390/inorganics9080060

Chicago/Turabian Style

Tan, Yee Seng, Chien Ing Yeo, Edward R. T. Tiekink, and Peter J. Heard. 2021. "Dithiocarbamate Complexes of Platinum Group Metals: Structural Aspects and Applications" Inorganics 9, no. 8: 60. https://0-doi-org.brum.beds.ac.uk/10.3390/inorganics9080060

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop